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Abstract 
 
Background 
In the previous 20 years, numerous studies have shown associations between 
maternal hypothyroidism during pregnancy and various types of 
neurodevelopmental disorders in children. However, other studies have not 
found significant associations and the field is complicated by differing definitions 
of hypothyroidism.  
Aim 
This systematic review aimed to collect all articles on this topic, both 
observational studies and RCTs, and where possible perform meta-analysis to 
find out the overall significance of a given association, with a particular focus on 
the outcomes of intellectual disability, autism and attention deficit hyperactivity 
disorder (ADHD) with the exposure as the three types of hypothyroidism (overt, 
subclinical and hypothyroxinaemia).  
Method 
This involved searching through MEDLINE, EMBASE, PSYCHINFO, CINAHL, 
AMED, BNI, Cochrane, Scopus and Web of Science, as well as grey literature 
searching and citation chasing. Articles were screened for inclusion by two 
reviewers, and data extraction and quality appraisal was carried out by the 
primary reviewer and checked by a secondary reviewer. Random-effects meta-
analysis and narrative analysis were used.    
Results 
37 relevant articles were discovered and underwent data extraction. In total, we 
found that the association between indicators of intellectual disability and 
maternal hypothyroxinaemia was significant, with a combined odds ratio of 2.69 
(1.47-4.95). However, we did not find an association between subclinical 
hypothyroidism and indicators of intellectual disability or with maternal 
hypothyroidism with autism and ADHD.  
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Conclusion 
This study shows that the evidence supports the link between intellectual 
disability and maternal hypothyroxinaemia. Future studies should focus more on 
school age children and on autism and ADHD, and have larger cohorts.  
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Chapter 1: Introduction 
It has been known since the 19th century1 that a severe lack of iodine (less than 
50 µg a day in diet2), the key component of thyroxine, during pregnancy and 
early childhood can result in the syndrome of cretinism, characterized by severe 
lack of development, as well as deafness. Whilst cretins are known to have TSH 
levels between 312 and 150 mIU/l3, most cretinism occurs in endemic “goitre 
belts” such as Central Africa, where the natural intake of iodine is less than 
50µg (the US Institute of Medicine recommends an intake of 150μg for adults 
plus 220μg for pregnant women, the World Health Organisation recommends 
250 μg for pregnant and lactating women)4. The terms cretinism and congenital 
hypothyroidism are often used interchangeably, though there are some key 
differences. Congenital hypothyroidism, caused by a genetic inability of the 
fetus to produce thyroxine, is often less severe than cretinism caused by iodine 
deficiency, as the fetus can use thyroxine from the mother during development. 
At birth, further problems can be avoided by immediately treating the child with 
levothyroxine (congenital hypothyroidism is something that is routinely checked 
for) 5. Though hypothyroidism in young children is relatively rare in developed 
countries these days, hypothyroidism in adults, linked to advanced age and 
autoimmunity is much more common, with roughly 2% of the UK women having 
the condition6. However, thyroid function changes in women during pregnancy, 
in part because thyroid-binding-globulin levels increase (reducing the detectable 
level of thyroxine) 16, possibly in order to transport more thyroxine to the 
placenta17. As a result, the thresholds for hypothyroidism in non-pregnant 
individuals do not apply, and there is disagreement among physicians as to 
what thresholds to use in pregnancy (such as whether to diagnose 
hypothyroidism at TSH levels higher than 4.2 mIU/l or 2.5 mIU/l) 16.  
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In recent years there has been increased concern in the literature that adult 
hypothyroidism during pregnancy could result in more mild forms of 
neurodevelopmental disorder in the child (relative to cretinism). A key article 
was published by Haddow et al in 1999 showing an association between 
maternal hypothyroidism and reduced IQ scores in the children, with an IQ 
difference of 7 points between the children of untreated hypothyroid mothers 
and euthyroid mothers7. Maternal hypothyroidism has been implicated in other 
neurodevelopmental disorders, for example Román et al in 2013 showed that 
children born to hypothyroid mothers (namely mothers hypothyroid between the 
8th and 12th week of pregnancy) had a 4 times greater risk of developing autism 
than children born to euthyroid mothers8. Furthermore in 2004 Vermiglio et al 
found that in one cohort, 68.7% of children born to mothers with 
hypothyroxinaemia (due to living in a low iodine area) developed Attention 
Deficit Hyperactivity Disorder (ADHD), compared to 0% for mothers without the 
condition9. However, results have been conflicting, with Craig et al showing no 
significant difference in infant development between children born to euthyroid 
mothers and those born to mothers with hypothyroxinaemia10. Furthermore, 
Lazarus et al found no difference in IQ between those children whose mothers 
were treated for hypothyroidism (both subclinical and overt hypothyroidism) 
during pregnancy and those who weren’t11. Therefore, it is debatable whether 
mothers with milder forms of hypothyroidism (namely subclinical hypothyroidism 
and isolated hypothyroxinaemia, which often doesn’t present symptoms) should 
be treated with levothyroxine to reduce the incidence of Neurodevelopmental 
Disorders (NDD).       
In the next section, the basic nature of human thyroid function will be discussed, 
and how thyroid homeostasis is different in pregnancy (and how hypothyroidism 
can affect pregnancy). The following section (page 19) will introduce the 
differing types of neurodevelopmental disorders, and relevant issues regarding 
their diagnosis and aetiology. This will be followed by an analysis of possible 
mechanisms by which maternal hypothyroidism could result in 
neurodevelopmental disorders (page 26) followed by a summary of the aims of 
this project (page 39).   
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Hypothyroidism and pregnancy 
Thyroxine and Thyroid homeostasis 
The Thyroid gland is a butterfly shaped organ found in the neck next to the 
trachea (i.e. windpipe). Thyroxine (T4) is a key hormone for speeding up the 
body’s metabolic rate (in part due to priming the body to respond to 
adrenaline12`) and is a key hormone for development, in particular the brain (in 
part due to promoting neuronal migration via the Reelin pathway 13).  The active 
form of Thyroxine in the body is Triiodothyronine (T3). Most of the T4 and T3 is 
bound in plasma proteins, including Thyroid Binding Globulin (TBG)17 which 
keeps them inactive, hence the active hormones are unbound and referred to 
as free thyroxine (fT4) and free Triiodothyronine (fT3).Thyroxine is regulated via 
a negative feedback pathway, in which Thyroid Stimulating Hormone (TSH) 
from the pituitary gland (a small gland below the brain) stimulates the 
production of the active hormone fT3 and the inactive fT4 (which is converted to 
fT3 on site) in the thyroid gland, the fT4/fT3 then inhibiting the production of TSH 
14. TSH is ultimately released from the pituitary gland due to the release of 
Thyrotropin Releasing Hormone (TRH) from the hypothalamus in the brain, 
which is released in response to low TSH. TRH is released in response to 
numerous other stimuli, including cold temperatures, as thyroxine raises the 
body temperature 15 (see Figure 1 for more details).  
Thyroid homeostasis in pregnancy  
TSH is often suppressed during pregnancy, as Human Chorionic 
Gonadotrophin can also stimulate fT4 production, reciprocally suppressing TSH 
in the process 16.  Furthermore increased levels of thyroid-binding-globulin 
(TBG) are released during pregnancy, making the measurement of T4 levels 
more difficult 16. It has been suggested that these changes during pregnancy 
are to help facilitate the transport of T4 to the placenta and on to the fetus17. 
However, the placenta is also known to produce deiodinase enzymes to convert 
the T4 to inactive rT3 (reverse triiodothyronine) 18, hence the transport of iodine 
to the fetus may be more important.17 
Forms of hypothyroidism 
The symptoms of hypothyroidism include fatigue, weight gain without eating as 
much and sensitivity to the cold 19. There are three different recognised forms of 
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hypothyroidism, based on variations on the levels of both fT4 and TSH. One 
form is overt hypothyroidism, which is characterised by low levels of fT4 and, 
due to reduced negative feedback, increased TSH. This form of hypothyroidism 
is associated with full onset of the symptoms and doctors will treat this condition 
with levothyroxine16. There is also the form of subclinical hypothyroidism, 
characterised by normal levels of fT4 but elevated levels of TSH 16. There are 
often no visible symptoms of subclinical hypothyroidism 20, and treatment of this 
condition is not universally agreed upon16 (though it is often treated during 
pregnancy), even though some studies have linked it to health problems, such 
as elevated cholesterol 21. Furthermore there is the form known as isolated 
hypothyroxinaemia, which occurs in pregnancy and is characterized by normal 
TSH but low levels of fT416. A problem with all of these forms is that different 
researchers use differing definitions of what “low” fT4 and “high” TSH levels 
mean. In an attempt to bring standardisation, the American Thyroid Association 
states that during pregnancy, low fT4 is defined as levels below the 10th 
percentile average, and elevated TSH is defined as levels above 2.5 mIU/l  in 
the first trimester and 3 mIU/l in the second and third trimesters22.  
Causes of hypothyroidism 
There are many different ways that hypothyroidism can be caused, and different 
causes bring different levels of severity. Overt hypothyroidism is often 
associated with Hashimoto’s disease, also known as Autoimmune Thyroid 
Disease, in which the immune system attacks the thyroid gland 16. This involves 
a T-cell with an antigen for a thyroid protein being activated, stimulating the B-
cells to secrete antibodies against thyroid proteins23. This often occurs following 
a bout of thyroiditis, the inflammation of the thyroid gland. It is theorised that 
Hashimoto’s disease originates from the immune system attacking a thyroid 
protein that resembles a viral protein, though clear evidence is lacking23. 
Thyroiditis can be brought about in many ways, the most common being 
postpartum thyroiditis, where a mothers immune system becomes hyperactive 
after being suppressed during pregnancy, allowing existing autoimmunity to 
become manifest24 25. It has been proposed that postpartum thyroiditis could 
result from an immune response to fetal cells that have migrated from the fetus 
to settle in the thyroid gland23. Though often seen as a temporary phenomenon, 
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one study showed that in 64% of cases, postpartum thyroiditis lead to long term 
thyroid failure26.  
Thyroiditis can also be caused by infections to the thyroid gland, this includes 
subacute thyroiditis (characterised by pain in the thyroid) which is believed to be 
caused by enterovirus infection (due to the fact that it often follows respiratory 
infections and peaks in occurrence in the summer) 21. Another infection includes 
suppurative thyroiditis, characterized by long term bacterial, fungal or parasitic 
infections of the thyroid gland. This rarely happens as the thyroid is quite 
resistant to infection, hence suppurative thyroiditis is often associated with AIDS 
patients23. Certain drugs are also known to cause thyroiditis23, these include 
Amiodarone, which has a high iodine content, which can overload the thyroid 
gland, causing a Wolff-Chaikoff effect (where the thyroid blocks uptake of 
iodine), followed by an immune system attack27. Other drugs that can cause 
thyroiditis include Lithium (used in mental health treatment) which can stimulate 
B-cell activity and inhibit thyroxine synthesis28 and Interferon alpha (used in 
Cancer treatment29) by stimulating B-Cell activity25.  
Subclinical hypothyroidism can be caused by all the things that cause overt 
hypothyroidism, but to a reduced extent. In fact, subclinical hypothyroidism is 
known to progress to overt hypothyroidism in many cases 21. Subclinical 
hypothyroidism is also linked to old age30; this may be linked to changes the 
immune system undergoes during aging. In particular, there are a group of B-
cells (carrying the CD19+CD24hiCD38hi phenotype) that are able to suppress 
other B-cells and T-cells by secreting Interleukin-10. This group of B-Cells have 
been shown in one study to decrease with advanced age, and this decrease 
correlates with increasing autoimmune disease (in this study rheumatoid 
arthritis) 31. Furthermore, isolated hypothyroxinaemia is linked to iodine 
deficiency in the mother; however a firm cause of isolated hypothyroxinaemia is 
unknown32.   
Hypothyroidism and Pregnancy Outcomes 
Hypothyroidism during pregnancy has been linked to numerous negative 
outcomes for both the mother and the child. Overt hypothyroidism is associated 
with an increased risk of miscarriage, pre-term delivery, pre-eclampsia, 
placental abruption, gestational hypertension, congestive heart failure, fetal 
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respiratory distress syndrome, increased need for caesarean section, low 
birthweight and neonatal death16. Subclinical hypothyroidism is also associated 
with miscarriage and pre-term delivery, however only one study has shown 
levothyroxine treatment of subclinical hypothyroidism to reduce these 
phenomena 16 33. Considering the association between subclinical 
hypothyroidism and advanced age, this is relevant information for women 
having children at an older age or perimenopause. Isolated hypothyroxinaemia 
has been associated with increased risk of placental abruption, pre-term 
delivery and increased use of caesarean section32, however most studies have 
not shown a risk associated with isolated hypothyroxinaemia and as such isn’t 
treated16. Pre-term birth and miscarriage are both associated with the presence 
of thyroid autoantibodies regardless of whether the mothers showed signs of 
hypothyroidism, this possibly being linked to a general association between 
maternal autoimmunity and pre-term delivery/miscarriage, where the immune 
system initiates labour34. Furthermore hypothyroidism could contribute to 
placental abruption by increasing the coagulation rate of the blood, reducing the 
oxygen reaching the placenta35.    
Overt hypothyroidism, sub-clinical hypothyroidism and isolated 
hypothyroxinaemia have all been associated with decreased IQ and behavioural 
problems in the offspring, which is the main focus of this thesis.  
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Figure 1: Diagram of Thyroid Homeostasis 
 
TRH from the brain stimulates the pituitary gland to release TSH, which 
stimulates the thyroid gland to release thyroid hormones (T3 and T4), which then 
represses TSH and TRH secretion in a negative feedback loop36.   
 
Neurodevelopmental Disorders in Childhood 
Neurodevelopmental disorders (NDD) are defined by Diagnostics and Statistics 
Manual 5 (DSM5) as “a group of conditions with onset in the developmental 
period [i.e. children]” 37(p31) going on to say, “The disorders typically manifest at 
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an early stage in development, often before the child enters grade school, and 
are characterized by developmental deficits that produce impairments of 
personal, social, academic, or occupational functioning” 37(p31). According to 
government figures, between 3 and 4% of UK children have an NDD, which are 
often co-morbid with each other and physical disabilities38. Furthermore, 
neurological studies often point to overlapping brain structure anomalies in 
NDD’s, namely a difficulty in forming long distance neuron connections within 
the brain39 40 41 42 43 44.  
An editorial in 2012 by Michael J Owen proposed that all NDD are part of a 
continuum of brain dysfunction, ranging from neonatal death due to severe 
brain abnormalities up to mild behavioural difficulties. From this he suggested 
that all NDD’s share a common aetiology. This was based on the observation 
that intellectual disability is three to five times more prevalent in the 
schizophrenic population than the general population, and that numerous gene 
polymorphisms linked to schizophrenia are also linked to other psychiatric and 
neurodevelopmental conditions45.   
Types of neurodevelopmental disorder 
There are about 12 basic types of NDD that are currently recognised by DSM-V, 
with numerous subcategories37. Of key significance to this thesis are intellectual 
disability, autism spectrum disorders (ASD), language disorder, attention deficit 
hyperactivity disorder (ADHD), specific learning disorders such as dyslexia and 
dyscalculia, developmental coordination disorder (i.e. dyspraxia) and Tourettes 
Syndrome.  
Intellectual disability, historically known as mental retardation (a term still used 
by ICD-1046), is characterised by severe deficits in abstract reasoning, resulting 
in difficulty living independently. DSM5 measures it in terms of adaptive 
function37; whilst ICD-10 identifies it by an IQ less than 70 (DSM5 also 
measures IQ, but sees it as less important than adaptive function). Intellectual 
disability often co-occurs with global developmental delay, the failure to meet 
key developmental milestones (such as walking, talking and toilet training) at 
the appropriate age, used on children younger than 5 years.   
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Autism spectrum disorders are characterized by deficits in social behaviour 
(such as a lack of reciprocity and understanding of non-verbal communication), 
delayed (or in some cases absent) language development and repetitive, 
restrictive behaviour. This is linked to Language Disorder, characterized by an 
inability to pick up language skills (like vocabulary and grammar) that is 
substantially below what is expected for their age and not explained by another 
condition i.e. deafness.  
ADHD (also known as hyperkinetic disorder in ICD-1046) is characterized by 
severe inattention (missing details, poor focus,  losing things, not listening, 
failure to complete tasks etc.) combined with hyperactivity and impulsivity 
(fidgeting, inability to sit still, movement in inappropriate/dangerous contexts, 
excessive talking etc.) Symptoms have to be present before the age of twelve, 
and that the symptoms occur in two or more settings.  
Specific learning disorders are difficulties in a specific academic skill over a 
period of six months despite interventions. This includes dyslexia (a specific 
disorder of reading and writing, characterized by reading words slowly and 
incorrectly) and dyscalculia (a specific disorder of arithmetic skills).  
Developmental coordination disorder, or dyspraxia, is characterized by 
acquisition and executive control of motor functions (i.e. movement) that is 
substantially lower than what would be expected for that age (such as 
clumsiness and difficulty catching objects).   
Tourettes syndrome is characterized by rapid, uncontrolled, non-rhythmic motor 
or vocal movements, which is similar to other stereotypic movement disorders, 
characterized by repetitive and seemingly purposeless movement37. 
Overlap between neurodevelopmental disorders 
Increasing evidence suggests that the rate of co-morbidity between NDD is very 
high. In particular, studies suggest that between 28 and 53 percent of autism 
patients show ADHD symptoms depending on the population sample47. This 
may seem strange, considering that autism and ADHD are often seen as 
opposite behavioural symptoms, with autism being an inability to shift focus and 
ADHD an inability to hold focus. However one study did show that many 
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children with ADHD have difficulty shifting focus in response to social cues47, a 
trait shared with autism. It has also been suggested that hyperactivity could 
result in a child being less able to form stable relationships with peers, thus 
delaying social development, resulting in autistic like behaviour later in life48. 
There is also an association between dyslexia and behavioural problems (one 
study found that 40% of children with ADHD also had reading difficulties) 49, and 
connections between childhood NDD and adult mental health, such as a link 
between autism and schizophrenia (some studies showing 34.8% of autistic 
patients having schizophrenia and 60% of schizophrenic patients having 
autism) 50. A key (though not only) link in this is intellectual disability, which is 
known to be highly comorbid with autism, ADHD and schizophrenia51. It has 
recently been suggested that much of the increase in autism diagnosis in recent 
years is due to the reclassification of children with intellectual disability as 
autistic52, though other researcher’s disagree53. This level of overlap suggests 
that there are blurred boundaries between differing NDD, rather than the 
discrete categories they are often presented as. Therefore this study aims to 
look at all neurodevelopmental disorders mentioned in DSM5 and 4, as a 
possible aetiology in one NDD may apply to others.   
Further evidence for a shared aetiology comes from the fact that there are 
shared brain structure abnormalities in these NDs. For one thing, corpus 
callosum abnormalities are observed in autism40, ADHD41 and Tourettes 
syndrome44, and hemisphere specific actions (hinting at a role of the corpus 
callosum in those processes) have been noted in language development39, 
pragmatic language disorder (linked to autism)54 and dyslexia55. Considering 
the role that the corpus callosum plays in the function of the brain, in terms of 
both coordinating movement on both sides of the body and allowing the reactive 
right hemisphere to influence the routine left hemisphere (more in the 
Mechanisms of Action section), it is not surprising that defects therein would be 
linked to NDD. An even more common abnormality found are frontal lobe 
abnormalities, observed in autism37, ADHD38, Tourettes44, other motor 
stereotypies43, developmental coordination disorder42 and dyslexia54. The 
frontal lobe acts as the main regulator for the brain, activating other parts of the 
brain when needed and inhibiting parts when not needed. Therefore its 
underdevelopment is likely to cause multiple cognitive and emotional problems, 
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hence its role in many types of NDD. Both of these commonly found 
abnormalities could be linked to a decreased ability of the brain to form long 
distance connections within the brain. This could be linked to decreased 
myelination, abnormal neuronal migration (more in the Mechanisms of Action 
section) or differences in chemoattractant levels needed for axons and 
dendrites to locate each other56.  Therefore, it is easy to see how disruption to 
brain development at an early stage can lead to multiple behavioural 
characteristics (manifesting as multiple, overlapping NDD), hence separating 
NDD into discrete diagnosis may be a false dichotomy.     
The overlapping nature of NDD could be exaggerated due to the methodologies 
used. For example it may represent a sampling bias, namely that the more 
severe patients of a type of NDD (in terms of both cognition and behaviour), 
who may be more likely to be comorbid, are possibly more likely to be brought 
to clinics, whilst less severe patients (who may be less comorbid) are more 
likely to be ignored48. However, population based studies have also shown high 
levels of comorbidity49, meaning the risk of sampling bias may be less 
significant.   
It should also be pointed out that many of these studies are based on parental 
report of the symptoms of NDD. It is known that parental report can introduce 
bias into a study, as shown by evidence relating children’s sugar consumption 
and hyperactivity. Here it was shown that where mothers, who believed their 
children became hyperactive when consuming sugar, believed their child had 
consumed sugar (when in fact it was a placebo) reported more hyperactive 
behaviour than mothers who were told their child was given a placebo57. This 
raises the possibility that over-concern on behalf of the parents could in turn 
result in over-diagnosis of patients with NDD, thus reducing the validity of the 
claim that NDDs overlap. At the same time, there are benefits to parental report, 
as parents may be able to observe behavioural trends that clinicians may miss, 
likewise clinicians may pick up traits that parents may miss58.  
All of this means that when investigating the link between maternal 
hypothyroidism and NDD’s, focussing on one diagnosis could result in much 
relevant information being lost, as it may be being investigated in an 
overlapping diagnosis instead. Hence for this project we are investigating all 
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neurodevelopmental disorders. Furthermore, if all NDD’s are found to be linked 
to maternal hypothyroidism, it would strengthen Owens claim that all NDD have 
a common aetiology and form less distinct categories as conventional 
psychiatry makes out.   
 
Mixed aetiology for autism 
Despite the evidence of a shared aetiology between multiple NDD, due to 
overlapping diagnosis and shared brain structure alterations, there is also 
evidence for a mixed aetiology for autism. Key evidence for this comes from the 
fact that single gene defects, like Fragile X and tuberous sclerosis, only account 
for 10% of autism cases59. Other evidence for this comes from brain structure 
studies, where regions all across the brain have been implicated in autism, yet 
few have been implicated consistently40 (for a list of some key brain regions, 
see Figure 2). This suggests that the autistic population consists of patients with 
insults to differing regions of the brain, yet showing the same outward 
behavioural phenotype (speculatively because the brain regions are part of a 
shared brain network). Twin studies have indicated that autism is highly genetic, 
up to 80% genetic in one study60; however a recent, larger population study 
found the genetic component to be closer to 50%61. Twin studies only measure 
how much genetics accounts for the variability of a trait in a given population. 
This means that twin studies in different populations can produce different 
results, for example height is 80% genetic within the Western World but 65% 
genetic in developing countries62, most likely owing to differing shared 
environmental conditions between the two populations. Even within a 
population, if a study says autism is 80% genetic, it could mean that for each 
individual it is 80% genetic and 20% environmental, or it could mean that for 
80% of the autistic population it is entirely genetic whilst for 20% of the autistic 
population it is entirely environmental, or it could mean any mid-point between 
those two alternatives. This means there is still room for an environmental 
influence on autism to be measured, and indeed, environmental factors in 
autism have already been found63.  
This all means that if a link between maternal hypothyroidism and autism (or 
indeed any other NDD) is found, it may only explain a small percentage of the 
24 
 
overall population of patients, even if the phenomena cuts across multiple NDD 
categories. However, if the link is found in multiple NDD categories, this would 
still suggest a common aetiology, strengthening Owens position. 
 
 
 
 
 
Figure 2: Names for different structures in the brain. 
 
The Cerebrum is the outer layer of the brain, where most cognitive processes 
take place, the forward facing part of the cerebrum is known as the frontal lobe, 
which is key to cognitive and emotional control. The Corpus Callosum is a large 
nerve that connects the two hemispheres of the brain. The striatum is a 
component of the Basal Ganglia, which is key to motivation to movement. The 
Hippocampus is a key memory centre in the brain, particularly for verbal and 
spatial memory. The Cerebellum is key to voluntary movement and fine motor 
ability. Less relevant to this study, the thalamus relays signals within each 
hemisphere, the hypothalamus is key to endocrine control (such as TRH) and 
the Amygdala is key for emotional memory, particularly fear64.  
Mechanisms of action for the association between maternal 
hypothyroidism and neurodevelopmental disorders 
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This section will review and discuss contemporary hypothesise on how 
hypothyroidism during pregnancy could impact brain development, and how the 
subsequent brain abnormalities could result in various NDD.   
There are many ways that maternal hypothyroidism could result in NDD’s, most 
likely is the role thyroxine plays in promoting neuronal migration within the 
developing brain. FT3 is believed to stimulate cells in the brain (namely Cajal-
Retzius neurons in the cortex and granule cells in the cerebellum) to produce 
the protein Reelin. Reelin acts as a scaffold for radial glial cells (by helping them 
maintain their shape) which in turn act as a scaffold for neurons migrating from 
the inner brain to the outer brain65. Reelin does this by inactivating Dab-1 (via 
ApoE and VLDL receptors), Dab-1 being an inhibitor of cell migration and 
filopodia formation66 (for more details, see Figure 3). Linked to migration, fT3 is 
more generally key in stimulating the production of the extracellular membrane, 
of which Reelin is part of. This includes stimulating the astrocytes to secrete 
many compounds, including laminin, fibronectin, basic fibroblast growth factor, 
epidermal growth factor and nerve growth factor (the growth factors stimulating 
further membrane protein secretion)67.  In the event of an absence of fT3, this 
can result in a smaller cerebellum and a smaller cortex that is dense in grey 
matter65, as the neurons are less able to form white matter connections due to 
being closer together.  
As well as neuron migration, thyroxine is also key in neuron differentiation, 
stimulating asymmetric cell division in the radial glial cells into apical 
progenitors, which migrate upwards towards the ventricles, and basal 
progenitors, which migrate along the basement membrane, forming a layer of 
cells under the apical progenitors (basal progenitors are largely found in the 
telencephalon/cerebrum)68, 69. This cell differentiation is possibly regulated by 
downregulating E2F-1 and Cyclin D1 whilst upregulating p27, all of these genes 
being linked to the cell cycle67.  
Thyroxine is thus key to both the migration of glutamatergic cells in the cortex68 
and to the differentiation of GABA-ergic cells in the cerebellum from Pax-2 
precursor cells70.    
The fetus begins producing thyroid hormone receptors during the 8th week of 
pregnancy, but the fetal thyroid gland is not active until the 12th week of 
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pregnancy70. In that time the fetus is dependent on the thyroxine of the mother. 
This time period also correlates with the first arm movements a foetus makes, 
suggesting a key role in psychomotor development71. Whilst the mother may 
provide the fetus with a source of fT4, it seems likely that the fT3 is produced in 
the foetus, probably within the brain itself, as the D2 enzyme is expressed in the 
fetal brain. The placenta also expresses the D3 enzyme to create inactive rT368, 
whilst this is seen by some as evidence of maternal thyroxine’s unimportance in 
fetal development72, it could simply be an attempt to prevent the fetus becoming 
hyperthyroid rather than blocking off maternal thyroxine altogether. 
 At later stages in pregnancy and childhood, thyroxine promotes the maturation 
of oligodendrocytes and stimulates them to produce myelin73, 67, allowing the 
white matter to become more efficient at sending signals within the brain. This 
later function is probably unconnected to maternal thyroid function; however it 
could be affected by iodine deficiency, which in pregnancy could be linked to 
maternal hypothyroxinaemia74.  
Given the role thyroxine (particularly maternal thyroxine) has in the developing 
brain, it does seem probable that maternal hypothyroidism would have a 
negative effect on the child’s brain development. 
Intellectual Disability and Psychomotor development 
The hippocampus is a brain structure required for the formation of long term 
memories, and is associated with verbal and spatial IQ. Though some studies 
link larger hippocampi to greater IQ75 (see Table 1), others associated smaller 
hippocampi to greater IQ, possibly due to increased dendritic pruning (removing 
unused brain connections so that used ones can be used more efficiently)76. 
The hippocampus is itself a part of the cortex, the outer layer of the cerebrum, 
the cerebrum being the most advanced (and largest) region of the brain, which 
controls voluntary movement in the body77. Increased cortical thickness is 
associated with increased IQ in some studies78, particularly in younger 
children79 (see Table 1). However, other studies have shown that increasing 
thinness of the cortex at different stages of development correlate more strongly 
with increased IQ, particularly in older children and adolescence80. This can be 
linked to dendritic pruning.  
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The corpus callosum is also important in IQ (see Table 1), being the main nerve 
connecting the two hemispheres of the cerebrum (likely consisting of many 
smaller white matter connections). A larger corpus callosum is often associated 
with a higher IQ81 (especially spatial IQ); most likely because the increased 
hemispheric connection allows for the more specialized hemisphere in a given 
subject to be activated when appropriate (i.e. the left hemisphere for language 
processing) plus allowing both hemispheres to be used when faced with a 
challenging task82. However, one study (Ganjavi et al) disagrees with the 
association with larger corpus callosum volumes and IQ, showing that in boys 
under 12, a smaller corpus callosum was associated with increased IQ83. They 
suggest that this is due to a combination of more efficient use of a single 
hemisphere and dendritic pruning.  
 In 1999, Haddow et al found an association between maternal hypothyroidism 
and lowered IQ scores in the child (including scores below 85 IQ points)7. This 
may in part be linked to underdevelopment of the hippocampus in children born 
to hypothyroid mothers.  Thyroxine is important in hippocampi development, 
mostly by stimulating the differentiation of hippocampal cells from dentate 
granule cells, this being achieved by upregulating the protein doublecortin84 (a 
microtubule linked protein). Cell migration is also important in the formation of 
connections within the hippocampus, thus nerve fibre malfunctions are 
observed in the hippocampi of hypothyroid rats, linked to increased expression 
of cell adhesion protein NCAM-180 (causing the cells to stick in place)85. 
Thyroxine plays a big role in promoting cell migration towards the cortex, 
allowing for the cortex to become thicker and for forming the layers of the 
cortex65. Thyroxine is important in the formation of the corpus callosum (as 
shown by many studies), largely because the formation of the corpus callosum 
is dependent on migrating glial, glutamatergic and GABA-ergic cells86. In fact, 
the first migration of cells begins between the 8th and 12th week of pregnancy 
(disruption at this point can result in corpus callosum agenesis)87, the same time 
when the fetus is dependent on maternal thyroxine. 
As well as IQ, maternal hypothyroidism is also linked to delayed development of 
motor skills (or psychomotor development) in the children88. Much of this can be 
linked to the deficits in the corpus callosum, which is important in bimanual 
coordination89 (though individuals without the corpus callosum can find 
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compensatory mechanisms to achieve bimanual action90). A much more 
important part of the brain for controlling movement is the cerebellum, which is 
linked to both fine motor skills and balance91 (see Table 1).  However, much like 
with the corpus callosum, individuals lacking a cerebellum can find 
compensatory mechanisms to achieve motor performance, such as one 
individual who can ride a bicycle92.  Thyroxine is key to the development of the 
cerebellum, being important to the maturation of the Purkinje cells93 (the only 
output neurons in the cerebellum, thus centre of motor control94) and to the 
migration of granule cells (a group of key input neurons95), mostly through 
repression of the Thyroid receptor apha196.  
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 Table 1: Summary of relevant brain regions significantly linked to neurodevelopmental disorders 
 Hippocampus Cortex/Cerebrum Corpus 
Callosum 
Cerebellum Enhanced 
Cortex-
Subcortex 
connectivity 
Decreased 
Frontal 
Lobe-
striatum 
connectivity  
Intellectual 
Disability (IQ) 
Yes 
(decreased 
volume) 
Yes (decreased 
volume) 
Yes 
(decreased 
volume) 
No No No 
Autism No Yes (Increased 
Volume, 
increased 
density) 
Yes 
(decreased 
volume) 
Yes 
(decreased 
volume in 
parts) 
Yes No 
ADHD No No Yes 
(decreased 
volume) 
Yes 
(decreased 
volume in 
parts) 
No Yes 
(particularly 
in girls) 
Developmental 
Motor 
Coordination 
No No Yes 
(decreased 
volume) 
Yes 
(decreased 
volume) 
No No 
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Autism 
At the time of writing, the most recent review on the brain structure and function in 
autistic spectrum disorders was published by Sungji Ha et al in 2015 in Experimental 
Neurobiology97. It describes how autism seems to be characterised by rapid total 
brain growth during early stages of development, followed by a decline in growth 
(relative to typically developing brains) around 10 and 15 years of age. This growth is 
characterised by increased size of the cortex surface area (see Table 1), but not in 
thickness, a phenomena possibly caused by underdevelopment of white matter 
connections (causing the neurons to arrange themselves evenly and unconnected 
rather than tightly and connected). This suggestion is further supported by 
abnormalities in brain gyrification observed in autism, with increased gyrification in 
some brain areas (i.e. the frontal lobe) and decreased gyrification in others (i.e. the 
medial parieto-occipital cortices).  The review also discussed white matter in autism, 
and the general association in autism with decreased long distance connections (i.e. 
inter-hemispheric) and increased short distance connections (i.e. striatal-cortical 
connections, see Table 1), though a few studies did find more general hyper-
connectivity in ASD children97.    
Due to the cerebellums role in movement, it was believed to play a role in shifting 
attention from one object to another98. An inability to do so would result in autism like 
symptoms, such as being focussed on a single area whilst being “disinterested” in 
others (see Table 1). However, more recent studies have suggested that the 
cerebellums role in attention seems to be entirely motor based, and thus irrelevant 
when discussing psychological behaviour99. Nonetheless, the cerebellum has been 
implicated in other symptoms of autism, such as motor stereotypies100, fine motor 
skills (a common deficit in autism101) and language development102 (language in 
particular being linked to fine motor skills). However, most studies seem to link 
autism to a larger (rather than smaller) cerebellum, though the cerebellar vermals 
lobules are smaller103. The cerebellar vermal lobules connect the cerebellum to the 
spinal cord (allowing the cerebellum to perceive movement of the body) and to the 
brain itself (allowing for conscious awareness of movement) 104 and are linked to eye 
movement105. Thus it is possible that the symptoms of autism could arise less from 
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reduced ability to move due to the cerebellum entirely, but from reduced perception 
of movement due to the cerebellar vermal lobules.       
Autism has also been associated with thickening of the cortex106, though studies are 
conflicted107 (see Table 1). This could result in autism by increasing the density of 
grey matter in the cortex, making it difficult to form long distance white matter 
connections within the brain. This would result in decreased connections between 
the frontal and temporal lobes, weakening social behaviour, and decreased inter-
hemispheric connections, affecting cognitive functions. Also it could result in 
increased short distance white matter connections within each hemisphere. This 
could include increased connections between the cortex and sub-cortical regions, 
resulting in motor stereotypies, and increased connections within the primary 
sensory cortex, altering sensory responses40. 
The role of cortex thickness is closely linked to that of the corpus callosum (see 
Table 1), which can be used as a marker of the amount of long distance white matter 
connections within the brain81. Much like the cerebellum, the corpus callosum plays a 
key role in motor skills development, namely bimanual coordination89, immediately 
linking it to autistic symptoms. In particular, the corpus callosum is important in 
learning new motor skills, whilst old skills are ingrained within the motor system 
(including the cerebellum).   The corpus callosum is also important in directed gaze, 
by controlling the bimanual movement of the eyes108. This is important in social 
behaviour, for recognising faces, emotions and in learning from other people, all 
things reduced in autism.  
Outside of its role in motor control, the corpus callosum is also important in cognitive 
control. It is believed that the two hemispheres of the brain are specialized to 
performing differing tasks, namely that the left hemisphere is specialized for carrying 
out routine behaviour and the right hemisphere for responding to novel behaviour109. 
Therefore, in the event of the corpus callosum being weakened, it is possible for one 
hemisphere to become too dominant, leading to autism like behaviour. For example, 
if the left hemisphere becomes too dominant, it could result in Asperger syndrome 
like behaviour, with language and writing skills functioning, but with the patient being 
unable to “break routine” (i.e. respond to novel stimuli) and with reduced sensory 
perception. On the other hand, if the right hemisphere becomes too dominant, it 
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could result in symptoms closer to dyslexia and classical autism, where many routine 
behaviours (including language and self-care functions) are highly underdeveloped 
or absent but with heightened sensory perception, possibly allowing some to have 
advanced visuospatial skills (such as drawing).   
In 2013, Román et al linked maternal hypothyroidism to an increased risk of autistic 
spectrum disorders8. This is possibly linked to deficits in the cerebellum, a part of the 
brain dependent on thyroxine and linked to autism. The thickening of the cortex 
associated with autism could result from decreased neuronal migration, causing the 
neurons to build up in one layer of the cortex rather than spreading to others, hence 
the role of thyroxine. Furthermore, hyperthyroidism is known to inhibit the 
proliferation of neural progenitor cells110, hence hypothyroidism could result in an 
increase of such cells. Indeed, increased numbers of immature cells have been 
found in autopsies of autistic brains111. However, congenital hypothyroidism is 
associated with a decrease in grey matter in the cortex rather than an increase112. 
Other studies have associated congenital hypothyroidism with increased cortex 
thickening in some areas with cortex thinning in others, consistent with reduced 
neuronal migration113. The corpus callosum is known to be smaller in both autism110 
(agenesis of the corpus callosum results in autism like behaviour114) and in maternal 
hypothyroidism115. In fact, the main role of maternal hypothyroidism in autism could 
be reducing the size of the corpus callosum, thus reducing the bimanual coordination 
and cognitive control associated with the corpus callosum. However, the roles of 
cortical thickness and the cerebellar vermis are still relevant to the link between 
maternal hypothyroidism and autism.  
ADHD 
An underdeveloped cerebellum could contribute to ADHD symptoms in a similar way 
to how it could contribute to autism, which is by affecting attention, albeit preventing 
the patient from holding attention rather than shifting it. This may seem paradoxical, 
considering that holding attention and shifting attention are seen as opposite 
functions; however the same phenomena can be interpreted differently by whoever 
is carrying out the diagnosis. For example, if a child is gazing towards a window 
during lessons, one psychologist could claim they are unable to hold attention, thus 
cannot focus on the teacher, another psychologist may claim they are unable to shift 
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attention, and is heavily focussed on something outside or on the window. 
Furthermore, the cerebellar vermis is also reduced in ADHD116, as it is in autism.  
More generally, ADHD seems to be associated with decreased white matter volumes 
and thus reduced connectivity between different parts of the brain. As well as the 
frontal lobes and the cerebellum, this also includes the frontal lobe with the striatum 
and parietal lobe (linked to decreased motor control, see Table 1), within the “default 
mode network” (linked to inability to focus on a task) and between the two 
hemispheres i.e. reduced corpus callosum size41. The corpus callosum itself could 
play a role in ADHD symptoms, both with its role in directed gaze108 (needed to hold 
attention) and that some of the symptoms of ADHD could be linked to increased right 
hemisphere activity109 i.e. responding more dramatically to novel stimuli, resulting in 
hyperactive behaviour. 
A recent study showed that there is a brain structure difference in boys and girls with 
ADHD, with ADHD boys showing decreased white matter in the primary motor area, 
with ADHD girls showing increased white matter in the medial orbitofrontal cortex 
(part of the prefrontal cortex, see Table 1). Considering that girls are believed to 
mature faster than boys, and that posterior parts of the brain mature before anterior 
parts, it seems probable that girls would use the prefrontal cortex more than boys of 
the same age, hence the differing structures117. The increased white matter 
measured in ADHD girl’s medial orbitofrontal cortex could reflect decreased 
branching of the white matter, forming thick cables that affect fewer areas of the 
brain. This study means that there are potentially differing aetiologies for ADHD in 
girls and boys.  
In 2014 Päkkilä et al linked maternal TSH levels to ADHD118. Furthermore, many 
studies have linked ADHD to decreased connectivity between the frontal lobe and 
the cerebellum41, the cerebellums development being dependent on thyroxine. The 
deficit in white matter associated with ADHD could be linked to decreased neuronal 
migration, hence the role of thyroxine. However, unlike autism, cortex thickening and 
increased local connections of white matter don’t seem to play as big a role in ADHD 
(it isn’t mentioned in the main review on the topic41). This hints at a possible 
mechanism for the differentiation of autism and ADHD in hypothyroidism. Namely, 
that autism may result from maternal hypothyroidism in an iodine sufficient context, 
34 
 
whilst ADHD could result from maternal hypothyroxinaemia in an iodine deficient 
context. Speculatively in autism, whilst the fetus lacks maternal thyroxine during the 
critical 8 to 12 week period (resulting in reduced neuronal migration thus an 
underdeveloped corpus callosum), once its own thyroid gland is active, it can use its 
own thyroxine to develop novel white matter connections. By contrast in ADHD, due 
to the fetus’ own thyroxine defects due to iodine deficiency9, the white matter 
network remains undeveloped. This would prevent the more autism typical behaviour 
(namely repetitive behaviour) from developing in ADHD, and links to the observation 
that ADHD brains are often less mature (as the white matter network is universally 
stunted).  
Päkkilä et al found that in girls, elevated maternal TSH levels were more strongly 
associated with ADHD symptoms than low fT4, with no association found for boys118. 
They suggested the increased association in girls could hint at a separate 
mechanism for ADHD in girls compared to boys, boys being diagnosed 3 times as 
often. This is not surprising; the brain structure abnormalities in girls with ADHD117 
could easily be brought about by a decrease in neuronal migration, hence the role of 
thyroxine. Furthermore, Ghassabian et al in 2011119 found that elevated TSH levels 
in mothers, but not lowered fT4 in mothers, was associated with increased 
externalising behaviour in children.  They suggested the reason for this was because 
increased TSH levels were a better indicator of mild low thyroid function than directly 
measuring fT4119.   
Confounding Factors 
Whilst maternal thyroxine could be important in the development of intellectual 
disability, autism and ADHD, it is possible that there are confounding factors linked 
to hypothyroidism that are causing the phenomena described, rather than low 
thyroxine levels itself. One potential factor could be low socioeconomic status, which 
is associated with low iodine intake and hypothyroidism in developing countries120, 
and to some extent in developed countries7. Low socioeconomic status is linked to 
intellectual disability121 and to ADHD122, however autism is linked to increased 
socioeconomic status123. This could be accounted for by differing diagnostic trends 
linked to social sensibilities, for example an autism diagnosis carrying fewer stigmas 
than an intellectual disability diagnosis. Other studies have failed to show a link 
between socioeconomic status and autism124.  
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Another confounding factor could be parental obesity, as hypothyroidism is 
commonly associated with obesity125. Maternal obesity is associated with many 
neurodevelopmental impairments, including cognitive impairments, autism and 
ADHD126. This link is further strengthened if the mother also has diabetes127. 
Maternal obesity is believed to impact brain development largely through 
inflammation against the fetal brain126.  
A major confounding factor (especially in the case of autism128) is the impact of 
autoimmune responses (including inflammation) against the fetal brain. 
Hypothyroidism is often caused by autoimmunity, and is often linked to other 
autoimmune diseases like type 1 diabetes129. Autoimmunity (or more accurately, 
maternal immune attack) is widely believed to be associated with autism, with 
antibodies interacting with the fetal brain, in particular attacking the cerebellum128. 
However, in a recent systematic review into the link between autism and 
autoimmunity, autoimmune hypothyroidism was the condition with the strongest link 
to autism130. Thyroid autoantibodies have been linked to damage to white matter131, 
which could contribute to symptoms of autism. Autoimmune disease has also been 
associated with ADHD132 and to intellectual disability via autism133.              
Hypothyroidism is also associated with advanced age134, and autism is associated 
with advanced maternal age135.  Advanced age is believed to be linked to autism due 
to an increased mutation rate in the gametes, leading to alterations in the genes 
responsible for brain development. Advanced maternal age is also hypothesized to 
be linked to increased concentrations of neurotoxins in the mother135. A recent 
systematic review found that ADHD was linked to younger parentage (itself linked to 
low socioeconomic status) 136.   
Another confounding factor is the role of Polycystic Ovarian Syndrome (PCOS), a 
condition found in between 5 and 10% of women of reproductive age, which is also 
linked to hypothyroidism137. Autism has been controversially linked to increased fetal 
testosterone138. As PCOS results in increased testosterone in the mother, it is 
therefore possible that it could then result in autism in the child. A major study in 
Sweden found such a link, with maternal PCOS increasing the odds of autism by 
59%139. Testosterone is believed to contribute to autism symptoms by increasing the 
overall size of the brain (hence the thickening of the cortex) whilst altering the 
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dendritic connections (hence the reduced size of the corpus callosum)139. Prenatal 
testosterone has also been associated with increased externalising behaviour140, 
though it has also been linked to increased development141.    
Conclusion 
In summary, it seems that maternal hypothyroidism may contribute to intellectual 
disability, autism and ADHD in three overlapping ways. One is by reducing neuronal 
migration within the cortex, reducing the formation of the hippocampus (needed for 
long term memory formation) and reducing connectivity within the cortex. The other 
is by reducing the size of the corpus callosum (also by reduced neuronal migration), 
reducing the patients’ capacity for bimanual motor control, directed gaze and efficient 
cognitive control of the left and right hemispheres. The other is by reducing the size 
of the cerebellar vermis, reducing the patient’s ability to perceive and respond to 
movement, thus reducing their motor development and potentially their language and 
social development. Furthermore, differences between the three diagnostic criteria’s 
could emerge due to differences in the exposure to maternal hypothyroidism, with 
acute exposure resulting in autism and chronic exposure resulting in ADHD and 
intellectual disability. Therefore, maternal hypothyroidism could be a common 
aetiology for these three NDD (hence this review will focus on these three NDD), 
strengthening Owens hypothesis. Despite these possibilities, there are still potential 
confounding factors in the form of socio-economic status, parental obesity, maternal 
autoimmunity, parental age and PCOS.  
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Figure 3: Neuronal Migration and Reelin. 
 
Part A shows the direction of neuronal migration within the brain; whilst part B shows the migrating neurons travelling up the glial 
cells142. Part C shows how Reelin interacts with the Very Low Density Lipoprotein Receptor (VLDLR) and the Apolipoprotein E 
Receptor 2 (APoER2) to promote actin reformation and thus glial cell formation and neuronal migration143. 
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Purpose of this Systematic Review 
Though the Haddow7, Román8 and Päkkilä118 studies have shown links between 
maternal hypothyroidism and NDD’s, the evidence is inconsistent. For example, a 
study by Craig et al in 2012 showed no significant association between maternal 
hypothyroidism and cognitive development in infants after adjusting for 
confounders10.  Therefore there is a need to examine all the evidence on the topic to 
see if there is a pattern, and why deviations from that pattern occur. 
At present, there are debates going on among clinicians on issues related to 
maternal hypothyroidism, in particular the issues on iodine supplementation144 and 
universal screening during pregnancy of thyroid disorders145. At present, the UK is 
one of the few countries that do not fortify salt with iodine, despite some estimates 
that doing so could increase the average IQ by 1.22 points per child, saving up to 
£4495 per pregnancy in wider society144. At the same time, there are potential risks 
to iodine consumption (i.e. the Wolf-Chaikoff effect27), plus such a decision would 
have its own monetary costs. It has also been proposed that all pregnant women be 
screened for thyroid disorders (including hypothyroidism) and those found with 
elevated TSH levels be treated with levothyroxine145. However, most cases of 
elevated TSH are subclinical hypothyroidism19, and at what level of TSH elevation 
should be treated is disputed16. Furthermore, some studies have found universal 
screening no more effective at reducing negative pregnancy outcomes than targeted 
screening33, and whether levothyroxine treatment can prevent NDD has also been 
questioned11.   
This study thus aimed to search the literature on the link between hypothyroidism in 
the mother and neurodevelopmental disorders in the child, to see if the evidence for 
such an association is robust. If the link is robust, it would be strong evidence in 
favour of universal screening of thyroid disorders. This study also aimed to examine 
the association between maternal hypothyroidism and numerous NDD (in particular 
autism, ADHD and intellectual disability), as there is considerable comorbidity 
between NDDs and they may share a common pathway in development. There have 
been non-systematic reviews on the topic most recently by Amed in 2015146. 
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However this review mostly focussed on the synthesis and transport of thyroxine 
within the developing brain, with a particular focus on the MCT8 transporter, rather 
than the impact of maternal hypothyroidism. A more relevant recent review was by 
Rovet in 2014147, which compared children born to hypothyroid mothers (HYPO) with 
children with congenital hypothyroidism (CH). Many differences were noticed, in 
particular that HYPO children have a somewhat less developed cortex whilst CH 
children have somewhat less developed cerebellums. Considering the link between 
cortex development and corpus callosum development81, and how the corpus 
callosum is strongly linked to most NDDs, this observation supports the mechanisms 
reviewed above.  
Furthermore a systematic review has been carried out on the link between maternal 
hypothyroidism and cognitive development by Wang et al in 2015148. The review 
found a strong association, though it did find evidence of publication bias.  
The current review aimed to search more databases (Wang et al148 only looked at 
Medline and Embase), and examine more neurodevelopmental outcomes (namely 
diagnosis of ND) and also analyse randomised controlled trials on the topic of 
whether levothyroxine treatment can prevent or reduce the severity of symptoms of 
NDD in children born to hypothyroid mothers, something that has not been done 
before. Wang et al148 can also be criticized for forcing studies measuring different 
outcomes into the same meta-analysis, which this study hopes to avoid.   
Another recent systematic review was by Spencer et al in 2015149, which looked at 
randomised controlled trials (RCT) to see how much does screening for thyroid 
disorders (and subsequent treatment) reduce negative outcomes in pregnancy, 
including low IQ.  The review found only one RCT on the topic of IQ, which came up 
with a negative association.  
The current review also looked for observational studies, and was specialized for 
looking for neurodevelopmental disorders (Spencer et al also looked into pre-
eclampsia and pre-term birth, among other things).  
Another recent systematic review was by Chen et al in 2016150, which looked into the 
association between autism and maternal autoimmune disease. Not only did they 
find a strong association, they also found that the strongest, and only statistically 
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significant association was between autism and maternal autoimmune thyroid 
disease. Much of this association seemed to be weighted due to the presence of the 
Andersen et al 2014 study, which had a population sample of 857,014151, however 
even after removing that study, the association between autism and maternal 
autoimmune disease remained strong.  
The current study did not examine the impact of thyroid antibodies (though that could 
be the basis of a future systematic review) and instead focused on the presence of 
thyroid hormones (fT4 and TSH) on both autism and other neurodevelopmental 
disorders.     
Therefore, the current review asked two main research questions. 
1. Is there an association between hypothyroidism in mothers and 
neurodevelopmental disorders in their children? 
2. Does levothyroxine treatment of pregnant mothers lead to a significant drop in 
diagnosis and/or reduction in the severity of symptoms of neurodevelopmental 
disorders in children?  
As part of the discussion, we looked into how differences in methodology account for 
different conclusions between articles on the topic. This study also studied mothers 
who had overt hypothyroidism, sub-clinical hypothyroidism and isolated 
hypothyroxinaemia during pregnancy and their children from those pregnancies. 
We planned to conduct a number of sub-group analyses if there is enough data (that 
is two or more articles per subgroup with compatible data), which included: 
1. Different types of hypothyroidism (overt, subclinical and isolated 
hypothyroxinaemia). 
2. Different definitions of hypothyroidism (fT4 levels in the 10th, 5th and 2.5th 
percentiles etcetera) 
3. Each specific neurodevelopmental disorder individually (autism, ADHD, 
intellectual disability) 
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Chapter 2: Methods 
A pre-defined protocol was developed following consultation with topic experts and is 
registered with PROSPERO (2016:CRD42016032790). 
Research questions and PICOs 
The first thing done when starting the systematic review was to decide precisely 
what information was being searched for. This required clear research questions, 
and from that an understanding of the populations, interventions or exposures, 
controls or comparisons and patient outcomes (PICO) that were being studied.  
After much discussion, two research questions were decided upon. 
Research Question 1: Is there an association between hypothyroidism in the 
mothers and neurodevelopmental disorders in their children? 
Population: All mothers where thyroid function tests were carried out during 
pregnancy, either as defined as overt hypothyroidism (high TSH with low fT4), 
subclinical hypothyroidism (high TSH with normal fT4) and/or hypothyroxinaemia 
(normal TSH with low fT4) or as continuous measures. The population also included 
all children where neurodevelopmental outcomes were measured after birth (no 
lower age limit was used, as neurodevelopmental symptoms can appear any time 
after birth), either as an explicit diagnosis or as measured on a continuous scale. 
The NDD’s being measured were the ones listed in Diagnostics and Statistics 
Manual 5th edition (DSM5)37, with additional terminology from International 
Classification of Diseases 10th edition (ICD-10)46. There was a particular focus on 
autism, ADHD and intellectual disability due to the high rate of co-morbidity, and 
these NDDs appeared a lot in scoping searches. Adult men and women without 
children were excluded from the population.  
Exposure: Maternal hypothyroidism as indicated by high TSH levels and/or low fT4, 
measured either at a cut-off point (such as fT4 below the 10th percentile) or as the 
lower half of a continuous measure.  
Control (i.e. Unexposed): Euthyroid mothers (as determined by the researchers in 
the articles).  
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Outcome: The frequency of diagnosis and/or the severity of symptoms of 
neurodevelopmental disorders in children. This included measuring the symptoms in 
undiagnosed children as a continuum.  
Studies: Observational studies were chosen for this research question. 
Research Question 2: Does levothyroxine treatment of pregnant mothers lead to a 
significant drop in diagnosis and/or reduction in the severity of symptoms of 
neurodevelopmental disorders in children? 
Population: All mothers with any diagnosis of hypothyroidism as defined by the 
researchers (including levels of fT4, TSH and hospital diagnosis). As with question 1, 
the population also included all children where neurodevelopmental outcomes were 
measured after birth (no lower age limit was used, as neurodevelopmental 
symptoms can appear any time after birth), whilst excluding adult men and childless 
women.  
Intervention: Treatment of the mother with levothyroxine to eliminate the symptoms 
of hypothyroidism. We considered looking into iodine treatment as well, however 
iodine treatment is of little use to mothers with autoimmune hypothyroidism (the main 
focus of this study) hence to decrease work load we focussed on levothyroxine 
treatment.  
Control: Mothers whose hypothyroidism was left untreated. 
Outcome: The frequency of diagnosis and/or the severity of symptoms of 
neurodevelopmental disorders in children. This included measuring the symptoms in 
undiagnosed children as a continuum. 
Studies: Randomised controlled trials (RCTs) were chosen for this research 
question. 
It was decided that a systematic review would be the best way to answer these two 
questions, as systematic reviews reduce the risk of selection bias by the 
researchers, due to the fact that they provide “explicit, pre-specified and reproducible 
methods”152(p. V) on how to search for articles and extract data from those articles. 
Systematic reviews thus collect all available evidence on a given topic152. They are 
considered “gold standard” evidence.  
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Searches 
Searches were carried out between November 2015 and February 2016. To search 
the literature, a core set of search terms were used based on the PICOS used 
above, which were then adapted for the map terms used in each database, hence a 
slightly different search strategy was used for each database (the search terms are 
available in the appendix section (see appendix 1 to 7). At its core, the search 
strategy consisted of three blocks, the first terms for hypothyroidism, the second 
terms for NDD’s and the third terms for mothers and pregnancy. The three blocks 
were joined together in the searches using AND operators, and were held together 
internally using OR operators.  
The search terms we used for neurodevelopmental disorders were the standardized 
terms, namely those from the 4th and 5th edition of the Diagnostics and Statistics 
Manual for Mental Disorders (DSM-IV and DSM-V)37 with additional terminology from 
International Classifications of Diseases 10th edition (ICD-10)46. DSM terms are 
established in systematic reviews dealing with neurodevelopmental disorders153.   
9 databases were searched using 6 interfaces. MEDLINE, EMBASE and PsychInfo 
were searched using OVID. CINAHL and AMED were searched using EBSCOhost; 
the British Nursing Index was searched using ProQuest, the Cochrane Central 
Register of Controlled Trials was searched using Wiley, Scopus was searched using 
Elsevier and Web of Science was searched using Thomson Reuters.  
To reduce the risk of publication bias, we decided to look for information outside of 
academic journals on top of our database searches.    
Alerts were also set up to inform of any new articles of the topic. This included 
Google alerts, and Web of Science also sent alerts linked to the saved search to the 
account holder.  
Only titles and abstracts were searched for. See appendices 1 to 7 for the list of 
search terms used for each database. 
The results from the searches were stored on EndNote154 before deduplication took 
place. 
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Methods for Grey literature searching 
 
A Grey Literature search was also carried out using GreyLit, OpenGrey and Grey 
source 
For searching Grey Literature Report, Boolean operators were not allowed, thus the 
individual search terms were used, and a title screening (plus quick full text analyses 
where available) was used to pick out any relevant reports. The relevant hits were 
then downloaded as Bibtex and then opened on EndNote, though the data often had 
to be filled into the reference manually.  
For Greysource, a list of directories to other grey literature sites was given. When 
checking the biological and medical sciences section on GreySource, it seemed to 
link back to OpenGrey. Here OpenGrey seemed to work, without producing a white 
screen.  
We had planned to search OpenGrey directly (rather than through GreySource), 
however due to a technical fault with the website; we were unable to do so. 
For institutions linked to neurodevelopment, we checked the following charity 
websites linked to autism:  Autistica, Autism Speaks, Dame Shirley Foundation, 
INSAR, Simons Foundation, Waterloo foundation and NAS. These foundations also 
look into wider neurodevelopmental topics. For searching Autistica and the Simons 
Foundation, the same search term was used as for Scopus.  For the other websites, 
we simply searched for hypothyroidism, thyroid and thyroxine separately. A title 
screening was then performed to see if an article was relevant. For the Dame Shirley 
Foundation, we were unable to search the site, so a title screening of the ‘Articles 
Press and Media’ section was performed. 
For institutions linked to thyroid dysfunction, we checked the following institution 
websites: British Thyroid Foundation, British Thyroid Association, Society for 
Endocrinology and the American Thyroid Association. We used the same search 
terms as we used for Scopus. Where this was not possible, we searched for each of 
the neurodevelopment terms separately.  A title and report screening was done on 
the results to see if anything relevant appeared. We were unable to search the 
website of the British Thyroid Association. When an article was found, the original 
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library was checked to see if it had already been found in the earlier literature 
searches. The American Thyroid Association mostly linked to and commented on 
published articles, hence searching it was abandoned.   
Methods for Backwards Citation Chasing 
Here the primary reviewer went to the reference section of each agreed article. They 
then did a title search of the references, and if a reference seemed to match the 
protocol criteria, that title was selected. It was then checked to see if the article had 
already been found in the full library, or if it had already been excluded. If not, the 
article would then be located, and an abstract and full text screening would take 
place. If it still matched the protocol criteria, it would be added to a new library for 
backwards citation chasing.  
Methods for Forwards Citation Chasing 
Here the primary reviewer used the database Scopus. There the title of each agreed 
article was placed into the Document search. Once the title was found, the “papers 
citing this” section was chosen, showing all the articles that had cited the article. A 
title screening was done to see if any of the references matched the protocol criteria. 
It was then checked to see if the article had already been found in the full library, or if 
it had already been excluded. If not, the article would then be located, and an 
abstract and full text screening would take place. If it still matched the protocol 
criteria, it would be added to a new library for forwards citation chasing. 
 
Methods for Results screening 
The following process was based on guidelines from the CRD handbook, chapter 
1.3.2155.  
Removing Duplicates 
All the citations found during the systematic searches were placed in one combined 
EndNote library for all of the databases. The duplicate results were removed in two 
waves, firstly by using the “find duplicates” function in EndNote, followed by a sifting 
through of the duplicates to retain the citation with the most information (for example 
one duplicate may have an abstract whilst the other wouldn’t). This was followed by 
manually sifting through the citations to delete duplicates the in-built function missed.  
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Title and Abstract Screening 
The de-duplicated citations were then read, and were included and/or excluded for 
full text analysis. Citations were excluded if: they were an animal (rather than 
human) study, they were before 1994 (when DSM-IV was released156), 
environmental pollution , cancer, iodine deficiency rather than thyroid hormone 
imbalance, single genes or diseases/syndromes other than hypothyroidism, vitamins 
and minerals in diet, Graves’ disease or hyperthyroidism without mention of 
hypothyroidism, assays, children with hypothyroidism but not the mothers, 
antibodies, cost-effectiveness, women’s mental and physical health but not the 
child’s, brain structure, neurodevelopment and mental health without hypothyroidism 
and if it was a Review, Commentary, Editorial, Letter or Erratum.  
After the primary reviewer had included and excluded the citations as they saw fit, 
two half libraries were created and sent to two secondary reviewers to analyse. Once 
they completed their analysis, they sent their results back to the primary reviewer. 
The primary reviewer then merged their results and the original results into a new 
library, and used smart groups (an EndNote function) to arrange the citations into 
four groups: those the primary and secondary reviewers agreed to include, those 
they agreed to exclude, those the primary but not secondary reviewers wanted to 
include and those the secondary reviewers but not the primary reviewer wanted to 
include. A meeting was then held looking at the citations they disagreed on (to see if 
those citations should be included after all), and all the citations they agreed on went 
on to full text screening. This method was used to improve inter-rater reliability. 
Full text screening 
For the agreed citations, the full texts were searched for and attached to the 
EndNote citation as PDF files. Most of the full texts were extracted using the in-built 
full text finder function on EndNote. Some full texts failed to be picked up by the in-
built function (such as those published to the Journal of Clinical Endocrinology and 
Metabolism) and had to be attached to the citation manually. Some full texts were 
not available for free online, thus had to be ordered from the British Library. Some of 
the agreed citations on closer screening turned out to be Conference abstracts, thus 
had no full text available, and had to be excluded.  
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With the full texts assembled, they were read sequentially and included or excluded 
for data extraction. This was done by filling the in/ex column with 0 for include or a 
special number for exclude depending on the reason they were excluded. The full 
texts were excluded if: the wrong population was being analysed (designated 2), the 
wrong intervention was given/exposure measured (3), the wrong comparison group 
was used (4), the wrong outcome was being measured (5), it was the wrong study 
design (6), it was a review or editorial or commentary (7), it was a duplicate 
(particularly a foreign language duplicate, 8) or it was a Conference abstract.  
After the primary reviewer had included or excluded the full texts, they halved the full 
text library and created two new libraries to send to the two second reviewers. They 
also included and excluded the full texts, using the same principle, but put their 
results in column 8 in the citation. The second reviewers sent their libraries back to 
the primary reviewer after completing their analysis, one library at a time. The 
primary reviewer then arranged the full texts into (non-smart) groups within the 
libraries sent to them based on four premises: those articles both the primary and 
secondary reviewers agreed to include, those they agreed to exclude, those the 
primary reviewer but not the secondary reviewers wanted to include and those the 
secondary reviewers but not the primary reviewer wanted to include. All 
disagreements were dealt with via Email, and the agreed full texts went on to data 
extraction.     
Methods for Data Extraction 
Once the final selection of articles was assembled, the key information had to be 
selected for data analyses. Therefore, the primary reviewer read through each article 
again, and copied the key information into a readily prepared data extraction form (a 
blank version of the one used can be found in appendix 8). The data extraction form 
used was a modified version of a data extraction form used for a systematic review 
into the use of mindfulness therapy. Use of a data extraction form helps reduce bias 
in the study, as it forces the reviewer to choose specific data about the article. It also 
saves time as only the most necessary data has to be extracted (to fill in each form).    
Initially, a pilot data extraction form was used on one article (to test whether more or 
less information needs extracting), with the aim of extracting the following key data: 
Bibliographic information, the setting of the study (i.e. the country and the 
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intervention site), the time of the study, the study design, the funding sources, the 
study aims, the age of the mother during pregnancy (if available), the age of the child 
when assessed, the type of hypothyroidism being assessed, how that 
hypothyroidism was defined, the neurodevelopmental disorder being measured, how 
that neurodevelopmental disorder was measured, excluded groups, who and where 
was the study carried out, whether levothyroxine treatment was measured, the 
control group used, the follow up period, the statistical analyses, the number of 
people in the study, the number lost to follow-up and how much more likely were the 
case children to have neurodevelopmental disorder diagnosis and symptoms 
compared to control children (as measured via odds ratios, beta values and p-
values). 
After the pilot was used, it was further modified to include new information, namely 
how were the thyroid hormones measured and demographic differences between 
groups (either the case and control groups or the included and excluded groups).  
This process of copying the key information into the form continued until there was a 
form for each selected article. During the process, similarities between some articles 
(such as using the same population sample) were noticed that had been missed 
during the screening process. These articles were subsequently merged as “sister 
papers”. When a data extraction form was completed, it was sent to the secondary 
reviewers to check for mistakes and for alternative decisions. Discussions would 
take place, and the data extraction results would be modified as seen fit. This later 
process also reduces bias in the process by providing a second opinion on the 
matter.      
Methods for Quality Assessment 
As the data extraction process was undertaken, simultaneously the quality 
assessment of the articles was taking place. This process assessed the risk of bias 
in the articles, for further analysis at a later part of the study. It is important to tell if 
the study is biased in terms of selecting candidates and in methodology, as that can 
artificially inflate or deflate the results. Furthermore, if studies with one type of results 
(i.e. positive) turn out to have a higher risk of bias than another set of type of results 
(i.e. negative) then this would be used as a key talking point during the discussion. 
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The quality assessment process involved answering questions about the article 
using sub-forms within the data extraction forms (see Appendix 8).  As the second 
reviewers checked the data extraction forms, they also performed their own quality 
assessment on the articles. Where disagreements were had, a discussion would be 
had and the risk or bias would be adjusted as seen fit (further reducing bias in the 
process). The results of the quality assessment would later be put into a Risk of Bias 
table using a different table for each of the methods used.    
Quality Assessment for Observational Studies 
For the observational studies used to answer question 1, the Downs and Black 
Checklist was used to assess the risk or bias157, as recommended by the Cochrane 
Handbook Chapter 13.5.2.3158. Here a list of 27 questions had to be answered Yes, 
No or Unable to Determine (UTD) about the article. These included questions like 
“Were the subjects asked to participate in the study representative of the entire 
population from which they were recruited?”  A full version of the checklist used can 
be seen in the data extraction form in appendix 8.    
Quality Assessment for Randomized Controlled Trials 
For the Randomised Controlled Trials used to answer question 2, the Cochrane 
checklist was used159. This checklist assesses the key risks of bias in an RCT (as 
discussed by the CRD Handbook chapter 1.3.4160), namely: selection bias, 
performance bias, detection bias, attrition bias and reporting bias. Here the reviewer 
has to rank 8 entries linked to these biases as having either low, high or unclear risk 
of bias, and use information from the article to justify why it was ranked as such. A 
full version of the checklist used can be seen in the data extraction form in appendix 
8.   
 Methods for Data Analysis 
Choosing Data for Meta-Analysis 
Many of the studies provided multiple sets of results, some with over 20 sets. To 
avoid bias, we had to choose carefully which set of results to use in the data 
analysis, rather than simply choosing the most positive result. Hence the following 
criterion was used. 
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1. For studies using multiple tests for the same outcome, the most commonly 
used test would be used (i.e. the Wechsler Intelligence Test would be used 
over an experimental intelligence test). 
2. Where available, the total score of the test would be used rather than a 
subsect of that test. 
3. Where a trait was measured over multiple time periods, the latest point of 
measuring would be chosen, as this is when the child is older, and 
neurodevelopmental traits at an older age tend to be more stable. Whilst 
some NDD’s recede by adulthood (making measuring at that stage less 
reliable) over 18s were excluded in this meta-analysis, hence this is irrelevant.  
4. When multiple cut-offs of TSH and fT4 were measured, the most extreme cut-
off was used. Similarly, when an outcome was measured both against a 
continuous thyroid hormone measure and against a cut off value (i.e. cut off of 
the 10th percentile fT4 for hypothyroxinaemia) the cut off value was used.  
5. When thyroid hormone samples were collected at multiple times in pregnancy, 
the earliest time was chosen, owing to the theory that hypothyroidism in early 
pregnancy is more problematic than later pregnancy.  
6. Where both fT4 and tT4 were measured, the fT4 measure was used, as fT4 is 
the more commonly measure for hypothyroxinaemia, and according to one 
study is as accurate a way to detect hypothyroxinaemia as tT4161. Studies 
where only tT4 was measured were included under hypothyroxinaemia. 
7. When a choice between an adjusted and unadjusted result was given, the 
adjusted result was used.  
 
Päkkilä et al 2014118 presented ADHD scores for girls and boys separately, but not in 
total. In that particular case we contacted the authors for gender merged results. We 
aimed to carry out 9 sets of meta-analysis, equating to the three primary NDD 
outcomes (ASD, ADHD and intellectual disability) multiplied by the three types of 
hypothyroidism (overt, subclinical and hypothyroxinaemia).  We also decided to carry 
out a meta-analysis of hypothyroxinaemia as defined by the 5th percentile fT4 levels 
or lower. 
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Though there are roughly 12 basic recognized types of NDD, for pragmatic reasons 
we decided to stick to autism, ADHD and intellectual disability for the meta-analysis, 
due to the high levels co-morbidity between those three NDD. 
Externalising behaviour measures were included in the ADHD meta-analysis, as that 
has predictive value for future ADHD162.  
Studies on Infant cognition were included in the intellectual disability meta-analysis, 
as infant-cognition can weakly predict later intellectual disability163. We decided to 
include measures of language as outcomes for intellectual disability. Whilst language 
scores could be used as outcome measures for autism and autistics traits, full autism 
diagnosis requires measures of other attributes like social behaviour and repetitive 
behaviour. Likewise whilst IQ usually measures a range of verbal and non-verbal 
attributes, verbal and non-verbal IQ are known to correlate strongly with each 
other164, hence a score of one can potentially predict the other. For this reason, 
performance IQ measures were also included as outcomes. 
We also decided to include studies of Developmental Delay as outcomes for 
intellectual disability, including the Mullen Scale of Early Learning and the Vineland 
Adaptive Behaviour Scale (both used by Yau et al194). These studies are contentious 
as they include motor development measures as well as cognitive measures. 
However, developmental delay is linked to intellectual disability (DSM-V uses global 
developmental delay as a diagnosis for children too young to be diagnosed with 
intellectual disability34).  Furthermore the Mullen Scale of Early Learning can be used 
to predict IQ165, and the Vineland Adaptive Behaviour Scale is used to diagnose 
Intellectual Disability166. Thus the developmental delay outcomes were included, and 
for this reason the combined Bayley Scales (Mental and Psychomotor) was also 
included.  
All of these measures constituted as indicators of intellectual disability, but not as 
explicit diagnosis of intellectual disability. 
Studies measuring autism and ADHD using both discrete diagnosis and validated 
continuous scales were included in this study. 
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Threshold Graphs 
In order to check for any outliers in the studies, and to check that a study was 
measuring the type of hypothyroidism it claimed to be measuring, graphs of the 
threshold values for the studies were constructed. 
In order to confirm that a given study measured the type of hypothyroidism it claimed 
to be measuring, a graph was plotted of all the studies, with the maximum absolute 
fT4 level measured to be diagnosed with hypothyroidism (in that study) against the 
minimum absolute TSH level needed to be diagnosed with hypothyroidism (in that 
study). If no fT4 was measured in a study, the study was given a 0 for its fT4 value in 
the graph, if no TSH was measured in a study, 0 was given for its TSH value in the 
graph.  
In order to check for outliers in the studies measures of neurodevelopmental 
outcomes, a graph was plotted of all the relevant outcome measures in the studies 
(thus only outcome measures for ASD, ADHD and intellectual disability) against the 
diagnostic/significance threshold for the measure, either as specified by the study or 
using the standard deviation of the population mean for that outcome (see Appendix 
9 for more details).  
Both of these graphs were made using Excel. 
 
Meta-Analysis 
Though many of the studies in the results gave odds ratios in the results, many of 
them gave continuous results and regression coefficients. Hence a key part of the 
meta-analysis was converting the continuous results and regression coefficients into 
odds ratios.  
To convert the continuous results, we used two equations, one by Suissa to gain the 
risk estimates and their variances167, the other one by Whitehead et al168 (based on 
Suissa et al) to gain the odds ratios and the variance of the odds ratios, from which 
the standard deviation (for the odds ratios) and confidence intervals could be 
calculated (see Figure 4 for further explanation). If we were defining positive results if 
the score was lower than threshold (as with IQ when measuring intellectual disability) 
the reciprocal of the odds ratio was used instead. In some cases, the studies did not 
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give an explicit threshold, in these cases the population mean minus the standard 
deviation of the population mean was used as a threshold. Many studies have used 
1 standard deviation below the population mean as a threshold in their investigations 
(including Haddow et al7) hence this decision is supported by researcher practice.  
Suissa et al claim their method is more accurate when dealing with small population 
sizes (such as less than 100 subjects) when compared to a binary approach to 
dichotomized data167. It is also an intuitive method, in that it is clearer where the final 
result comes from in the original data.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
54 
 
 
 
 
 
 
Figure 4: a graph showing the estimation of risk using methods from Suissa et al 
and data from Liu et al169.  
 
In this graph, the mean of IQ is 108 and the standard deviation is 9. The Suissa 
method is based on the assumption that the sample is selected from a Gaussian 
distribution, with the risk (from which odds ratios can be calculated) being the 
proportion of the normal curve below the threshold (in this graph the threshold is 99 
and specified by the red line).    
 
 
 
 
No established method could be found to convert the linear regression results to 
Odds Ratios; hence eight studies were excluded from the meta-analysis (though 
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they were included in narrative analysis alongside the meta-analysis). Linear 
regression can be reported in many different ways, the outcome can be measured 
against a continuous or discrete exposure, the outcome variable can be transformed, 
and the regression coefficient can be standardized or adjusted (or not). This high 
level of variation makes it difficult to find a consistent method to accurately convert 
them to odds ratios. 
For the linear regression results, we decided to use narrative analysis instead. Here, 
text without figures or calculations is used to summarise the nature and results of 
each study, with a conclusion based on the net number of results for or against an 
association.   
Where discrete results were presented in the study but no Odds Ratios were given, 
Odds Ratios were calculated in the standard method170; that is according to this 
equation. 
(a*d)/(b*c) 
Where a is the total exposed and with the disease, d is the total unexposed without 
the disease, b is the total exposed without the disease and c is the total unexposed 
with the disease.  
Once the odds ratios were calculated, they were then used to produce forest plots 
(using the metan function on STATA171) of the results. Forest plots display the 
pooled estimate of multiple odds ratios from different studies on a given topic (as 
well as the component odds ratios) showing the overall level of significance on a 
given topic. Each study was weighted using inverse variance and a random model, 
so that studies with a lower risk of bias will have a greater impact on the pooled 
estimate. Inverse variance means the greater the confidence intervals of an odds 
ratio, the lower its weight, and a random model means the weight from odds ratios 
that deviate from the other odds ratios is reduced171.  
A result was considered significant if it produced a p-value less than 0.05.  
Funnel plots (using the metafunnel function on STATA172) were also produced to 
measure publication bias. In order to use metafunnel, standard error had to be 
calculated, which was done using this equation. 
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SE = (lnUCI – lnOR)/1.96 
Where lnUCI is the log upper confidence interval and lnOR is the log Odds Ratio. 
 The statistical analysis was done using a combination of Excel173 and STATA174.  
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Chapter 3: Results  
Search results 
After searching all databases, 6041 articles were discovered. After removing the 
duplicate results, 3448 hits remained and after Title and Abstract screening, 59 
articles met the inclusion criteria. Of those 59 articles, nine were conference 
abstracts with no traceable journal article associated with them, meaning the 
methods could not be studied in depth, thus were excluded from study. A further five 
measured the wrong outcomes (such as psychiatric disorders and seizures), four 
were reviews, editorials or commentary, one measured the wrong exposure 
(maternal iodine deficiency) and one was a duplicate result (see Figure 5, a PRISMA 
diagram which shows the pathway to the included articles). One article, Noten et al 
2014175, was accepted into the study, but had to be ordered from the British Library, 
and could not be delivered until late into the project, thus was excluded. This left 37 
remaining full texts, of which one (Klein et al 2001176) used the same data as 
Haddow et al 19997, whilst two articles (Williams et al 2013177 and Korevaar et al 
2015178) used the same outcome measures on differing individuals from the same 
cohort as two other studies (Williams et al 2012179 and Ghassabian et al 2014180 
respectively). Haddow et al7 and Klein et al176 were merged as sister papers (the 
other articles were different enough to be treated separately), leaving 36 full texts in 
total (see Figure 5).  
During Grey Literature searches, no relevant articles were found on GreyLit and 1 
article was found on OpenGrey via GreySource which was unrelated to the protocol. 
No relevant articles could be found searching the institution websites either. 
During the forwards and backwards citation chasing, one other relevant article was 
discovered (Si et al 2012181), however the article was written in Traditional Chinese 
script. It was a British Library order, so could not be machine translated, and the one 
Chinese speaker available had difficulty understanding Traditional script, and had 
other academic commitments, hence to save time this article was excluded.    
Thus, 36 articles were included in this review (see Figure 5 and Table 2).     
Of those studies, only one, Lazarus et al11, was a Randomised Controlled Trial. 
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Exposure Characteristics of Observational Studies 
To make sure that the studies were measuring the type of hypothyroidism they 
claimed to be studying, and that the differing types of hypothyroidism were distinct, 
threshold graphs for the absolute cut-off values for the thyroid hormone 
measurements were created.  
When the first threshold graph was made, the tT4 values (from the studies Oken et 
al182 and Li et al183) were so vast that they made the rest of the graph unreadable. 
They were thus removed from Figure 6, though the tT4 values were still included in 
the analysis, as tT4 is another way of measuring hypothyroxinaemia. Figure 6 
showed that the studies measuring overt hypothyroidism, subclinical hypothyroidism 
and hypothyroxinaemia occupied distinctly different thresholds. An exception to this 
was Päkkilä et al 2015184, whose thresholds for overt hypothyroidism overlap with 
studies for hypothyroxinaemia. However, Päkkilä et al 2015184 is still an overt 
hypothyroidism study, because in hypothyroxinaemia those with TSH higher than the 
threshold are excluded from the diagnosis, whilst with overt hypothyroidism those 
with TSH higher than the threshold are included in the diagnosis, hence they are 
measuring different things (see Table 2).  
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Figure 5: the PRISMA diagram showing search strategy and exclusion criteria at 
each step.  
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Table 2: All studies for this project (sister papers merged). 1 
Name Study type N Male/ 
Female % 
Region/ 
Country  
Thyroid 
Dysfunction 
Assessed  
fT4 
measurements 
TSH 
measurements 
Age at 
Psychological 
assessment 
Outcome Measures 
1994 
Liu169  
Matched 
Cohort 
8 
hypothyroidism 
and 9 siblings of 
hypothyroidism 
NK China and 
Japan 
OH control range 
6.40-24.50 
pmol/l, case 
range 2.30-
6.30 pmol/l, 
control <5 
mU/l, case 
range 25-190 
mU/l  
4-15 years The Suzuki-Binet 
Intelligence Scale  
1999 
Pop88  
Cohort 220 55/45 Netherlands HR 15th percentile 
fT4 <10.90 
pmol/l, 10th 
percentile fT4 
<10.40 pmol/l, 
5th percentile 
fT4 <9.80 
pmol/l 
NA 10 months Bayley Scales of 
Infant Development  
1999 
Haddow7  
 
/2001 Klein176  
Matched 
Cohort 
62 
hypothyroidism 
and 124 controls 
1:1.4 ratio Maine, United 
States  
OH control 12.48 
pmol/l mean, 
case 9.14 
pmol/l mean 
98th percentile 
(control 1.40 
mU/l mean, 
case 13.20 
mU/l mean) 
7-9 years WISC, 3rd edition 
and Conners 
Continuous 
Performance test  
2000 
Smit205  
Cohort 7 hypothyroid, 6 
euthyroid and 7 
hyperthyroid 
1:1 ratio Netherlands SH NA >2-2.70 mU/l  6, 12 and 24 
months 
Bayley Scale of 
Infant Development 
(Touwens method 
at 6 and 12 months, 
Hempel's method 
at 24 months) 
2003 
Pop206  
Matched 
Cohort 
63 HR and 62 
controls 
Cases 
42/58, 
controls 
53/47 
Netherlands HR <10th 
Percentile 
(12.10 pmol/l) 
range 0.15-2.0 
mU/l 
1-2 years Bayley Scale of 
Infant Development 
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2006 
Kasatkina191  
Cohort 17 HR and 18 
controls 
NK  Russia HR reference 
range 12.0-
22.0 pmol/l 
range 0.27-
0.42 mU/l 
6,9 and 12 
months 
Gnome method, in 
particular the 
Coefficient of 
Mental 
Development 
(CMD).  
2006 
Kooistra198  
Matched 
Cohort 
108 HR and 96 
controls 
Cases 
52/48, 
controls 
52/48 
The 
Netherlands 
HR <10th 
Percentile 
(11.40-12.0 
pmol/l) 
range 0.15-2.0 
mU/l 
3 weeks Neonatal 
Behavioural 
Assessment Scale  
2009 
Oken182  
Cohort 500 50.4/49.6 Massachusetts
, USA 
Co tT4  
and SH 
normal tT4 
range 4.50-
10.90 μg/dl 
(57.92-140.28 
nmol/l) 
>2.50 mU/l 6 months and 
3 years 
Visual Recognition 
Memory  at 6 
months, Peabody 
Picture Vocabulary 
Test and Wide 
Range Assessment 
of Visual Motor 
Ability at 3 years   
2009 
Munoz193  
Matched 
Cohort 
29 HR  
and  
30  
controls 
NK Spain HR <10th 
Percentile 
(10.17 pmol/l) 
NA 2 years Parental report 
based on the 
criteria in DSM-IV 
for ADHD 
2010 
Henrichs192  
Cohort 3659 49.5/50.5 Netherlands HR and  
Co TSH 
10th percentile 
fT4 <11.76 
pmol/l, 5th 
percentile fT4 
<10.96 pmol/l 
range 0.03-
2.50 mU/l 
18 and 30 
months 
MacArthur 
Communicative 
Development 
Inventory at 18 
months, Language 
Development 
Survey at 30 
months 
2010 
Li183  
Matched 
Cohort 
19 HR,  
18 SH  
and 77  
controls 
NK China  SH and   
HR 
Hypo= 
tT4<2.50th 
percentile 
(101.79 nmol/l) 
SH=>97.50th 
percentile 
(4.21 mU/l)  
25-30 months Bayley Scale of 
Infant Development  
2011 
Ghassabian119  
Cohort 3736 49.9/50.1 Netherlands Co fT4  
and TSH 
<10th 
percentile 
(11.76 pmol/l) 
range 0.03-
2.50 mU/l 
18 months and 
3 years 
The Child 
Behaviour Checklist 
was used by 
mothers at 18 
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months and by both 
parents at 3 years 
2011 
Su196  
Cohort 1017 NK China SH <5th percentile 
(10.40-8.51 
pmol/l) 
gestation 
dependent 
>95th 
percentile 
(3.77-4.35 
mU/l) 
gestation 
dependent 
6 months Chinese Bayley 
scales for Infant 
development  
2011 
Chevrier201  
Cohort 287 48.8/51.2 California, 
USA 
Co fT4  
and TSH 
Low fT4 
defined as 
<6.44 pmol/l 
High TSH 2.50 
mU/l 
6 months and 
1, 2 and 5 
years 
Bayley Scales of 
Infant Development 
at 6, 12 and 24 
months,  WPPSI 
3rd edition  and   
Conner’s Kiddie 
Continuous 
Performance Test  
at 5 years   
2011 
Behrooz199  
Cohort 19 SH  
and  
19  
controls 
Cases 
42/58, 
controls 
53/47 
Iran SH NA SH=>3.0 mU/l 
control 1.40 
mU/l mean, 
case 11.30 
mU/l mean 
7.9 years for 
cases, 7.5 
years for 
controls 
WISC  
2012 
Williams179  
 
 
Cohort 166  
children  
and  
143 mothers 
53/47 United 
Kingdom 
SH and HR <10th 
percentile 
(11.6 pmol/l) 
3.0 mU/l 
 
5.5 years The McCarthy 
Scales of Children’s 
Abillities. 
2012 
Suárez-
Rodríguez207  
Cohort 37 HR  
and  
33  
controls 
NK Spain HR <10th 
Percentile (9.5 
pmol/l) 
range 1.07-
1.88 mU/ml 
38 months and 
5 years 
The McCarthy 
Scales of Children’s 
Abillities 
2012 
Craig10  
Matched 
Cohort 
98 HR  
and  
98  
controls 
46/54 Maine, United 
States  
HR < 3rd 
Percentile 
(11.84 pmol/l) 
range 0.10-3.5 
mU/l  
2 years Bayley’s Scale of 
Infant Development 
III  
2012 
Lazarus11  
Randomized 
Trial 
390 
interventions 
and  
404  
Interventi
on 55/45, 
control 
51/49 
United 
Kingdom and 
Italy 
OH and  
SH and  
HR 
Hypo and 
overt <2.5th 
percentile (95 
SH and overt 
>97.5th 
percentile 
(95% range 
3 years WPPSI, third 
edition and The 
Child Behaviour 
Checklist 
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controls % range 8.40-
14.60 pmol/l) 
0.15-3.65 
mU/l) 
2013 
Williams177 
Cohort 97 NK United 
Kingdom 
SH NA 2.50 mU/l 5.5 years The McCarthy 
Scales of Children’s 
Abillities. 
2013 
Julvez200  
Cohort 1761 1:1 ratio Spain Co fT4  
and TSH 
10th percentile 
fT4 <8.89 
pmol/l, 5th 
percentile fT4 
<8.39 pmol/l, 
2.5th 
percentile fT4 
<8.10 pmol/l 
90th percentile 
TSH >2.59 
mU/l, 95th 
percentile TSH 
>3.20 mU/l, 
97.5th 
percentile TSH 
>4.18 mU/l 
14 months 
average 
(range 11-23 
months) 
Bayley Scales of 
Infant Development 
2013 
Finken197  
Cohort 1765 48.4/51.6 Netherlands Co fT4  
and TSH 
fT4 10th 
percentile 
<7.70 pmol/l 
5th percentile 
fT4 <7.0 
pmol/l, 2.5th 
percentile fT4 
<6.50 pmol/l 
90th percentile 
TSH >2.30 
mU/l, 95th 
percentile TSH  
>2.90 mU/l, 
97.50th 
percentile TSH 
>3.80 mU/l 
5-6 years The Amsterdam 
Neuropsychological 
Tasks (ANT), a 
series of video 
game style tests 
measuring visuo-
motor skills, such 
as baseline speed 
(the first task) 
2013 
Roman8  
Cohort 4039 50.2/49.8 Netherlands HR <10th 
Percentile 
(11.82 pmol/l), 
<5th Percentile 
(10.99 pmol/l) 
NA 6 years Pervasive 
Developmental 
Problems on the 
Child Behavior 
Checklist for 
Toddlers (CBCL 
1.5-5), parent 
reported 
2013 
Andersen151  
Cohort 857014 NK Denmark OH Hospital 
Diagnosis 
(Denmark 
diagnosis 
<9.10 pmol/l) 
Hospital 
Diagnosis 
(Denmark 
diagnosis >5.0 
mU/l) 
3 years Hospital diagnosis 
of ADHD and 
Autism. Also 
prescription of 
ADHD medication. 
2014 
Ghassabian180  
Cohort 3737 1:1 ratio Netherlands Co fT4  
and TSH 
and HR 
<5th percentile 
(10.99 pmol/l) 
High TSH 
>2.50 mU/l 
6 years Snijders-Oomen 
Niet-verbale 
intelligentie test, 
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revisie (Mosaics 
and Categories) 
2014 
Yau194  
Nested 
Case-Control 
78 with  
autism,  
45 with 
developmental 
delay  
and  
149  
controls 
ASD 
87.18/12.
82, DD 
60/40, 
controls 
89.26/10.
74 
California, 
USA 
SH NA Neurodevelop
ment 
measured first, 
then compared 
to TSH levels 
(TSH in 
general 
population 
0.42-3.69 
mU/l) 
3-4 years Autism diagnosis 
based on DSM-IV 
specifications 
2014 
George195  
Case-Control 143  
with  
autism  
and  
200  
controls 
Cases 
83.7/16.3, 
controls 
57.5/42.5 
Kerala, India OH Hosptal 
Diagnosis 
(India 
reference 
9.48-19.58 
pmol/l) 
Hospital 
Diagnosis 
(India 
reference 
0.60-5.78 
mU/l) 
2-6 years Childhood Autism 
Rating Scale  
2014 
Pakkila118  
Cohort 348  
High TSH,  
66 HR  
and  
5131  
controls 
High TSH 
52/48, 
Hypo 
59.1/40.9,  
controls 
50.6/49.4 
Finland SH and HR 
and Co 
TSH 
Low fT4 
<11.40-11.10 
pmol/l 
gestation 
dependent 
high TSH 
>3.10-3.50 
mU/l gestation 
dependent 
8 years The Rutters B2 
scale  
2015 
Korevaar178 
Cohort 3839 49/51 Netherlands Co fT4  
and TSH 
Low fT4 <10.4 
pmol/l  
High TSH 
>4.04 mU/l 
6 years  Snijders-Oomen 
Niet-verbale 
intelligentie test, 
revisie (Mosaics 
and Categories) 
2015 
Modesto202  
Cohort 127 HR,  
3873  
controls 
(Generation R) 
1:1 ratio Netherlands HR <5th percentile 
(10.94 pmol/l) 
range 0.03-
4.04 mU/l 
8 years The Conners’ 
Parent Rating 
Scale-Revised 
Short Form (mother 
ranked) 
2015 
Grau208  
Cohort 39 controls,  
47 subgroup 1 
(HR)  
and  
51.2/48.8 Spain HR <10th 
Percentile 
(13.7-11.5 
pmol/l) 
range 0.01-5.0 
mU/l   
1 and 6-8 
years 
Brunet-Lezine  
scale and WISC-IV  
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369 subgroup 2 
(other iodine 
and thyroid 
problems) 
2015 
Ganaie186  
Cohort 43 uncontrolled 
hypothyrodism, 
39 controlled 
and 51 controls 
NK Kashmir 
Valley, India 
OH NA Control <10 
mU/l, 
borderline 10-
20 mU/l, 
abnormal >20 
mU/l,  
3-4 weeks Neonatal 
Behavioral 
Assessment Scale  
2015 
Pakkila184  
Cohort 5295 50.7/49.3 Finland OH and  
SH and  
HR 
Hypo and 
overt <11.40-
11.09 pmol/l 
SH and overt 
>3.10-3.50 
mU/l 
8 and 16 years Strengths and 
Weaknesses of 
ADHD Symptoms 
and Normal 
Behavior,  Teacher 
reported child 
school performance 
, Youth Self Report 
and WISC-Revised   
2015 
Murphy188  
Cohort 23 SH  
and  
47  
controls 
Cases 
52.2/47.8, 
controls 
51.2/48.8 
Ireland SH <2nd 
percentile 
excluded  
>98th 
percentile 
(>4.0-3.50 
mU/l) 
7-8 years WISC-IV  
2015 
Chen187  
Cohort 106 cases and 
106 controls 
NK China SH range 5.55-
15.8 pmol/l 
>3.47-4.99 
mIU/l 
12-24 months The Gesell 
development test 
(as revised by the 
Beijing Child’s 
Health Care Unit) 
1. OH=Overt Hypothyroidism, SH=Subclinical Hypothyroidism, HR=Hypothyroxinaemia, Co=Continuous, WISC=Wechsler 
Intelligence Scale for Children, WPPSI= Wechsler Preschool and Primary Scale of Intelligence   
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For Haddow et al7, the values used in Figure 6 were not the absolute threshold 
values, but the average values of the cases. The actual threshold for 76% of the 
cases was having a TSH level above the 99.7th percentile, the absolute value for 
which was not specified. For the remaining cases, the threshold was having a TSH 
level between the 98th and 99.6th percentile (absolute values not given) with a tT4 
count lower than 7.75 µg/dl (99.7 nmol/l). Thus within the study there was a mixture 
of participants with a measure of T4 and those without, with those without 
predominating. Although physicians often recommend levothyroxine treatment for 
TSH levels higher than 10 mIU/l regardless of fT4 levels19, for this thesis subclinical 
hypothyroidism was defined as elevated TSH with normal fT4, including studies 
where fT4 wasn’t measured. Furthermore, the Haddow et al study has been 
described before as a subclinical hypothyroidism study in the literature185 (even if it 
describes itself as an overt hypothyroidism study), hence Haddow et al was analysed 
under subclinical hypothyroidism. Ganaie et al186 was also viewed as a subclinical 
hypothyroidism study, as no T4 was measured at all in that study. 
Though Chen et al187 seems to stand out from the other subclinical hypothyroidism 
studies, that is because it was the only study specialising in subclinical 
hypothyroidism that mentioned the absolute fT4 threshold values it used to exclude 
overt hypothyroidism (lowest being 5.55 pmol/l). Murphy et al188 provided details of 
the percentile threshold values it used (2nd percentile) but not the absolute value, Li 
et al183 provided the threshold value in tT4 (101.79 nmol/l, which would be difficult to 
graph), the rest did not factor in T4 into their diagnosis or where continuous 
measures of TSH. Hence Chen et al187 was analysed as a subclinical hypothyroidism 
study. 
Andersen et al151 and George et al195 used hospital diagnosis for their measures of 
overt hypothyroidism rather than direct measures, hence the thyroid hormone values 
used in Table 2 and Figure 6 are based on data from Carlé et al (hypothyroidism 
thresholds for Denmark)189 and Unnikrishnan et al (hypothyroidism thresholds for 
India)190 respectively.  
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Figure 6: Thyroid hormone threshold graph without tT4 values 
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Outcome Characteristics of Observational Studies 
In order to check for outlier studies that defined NDD in a substantially different way, 
graphs were made of the thresholds used for NDD diagnosis by study.   
Figure 7 shows the chosen outcome measures for intellectual disability. Here a case 
was significant if they scored lower than threshold in any of these tests. For 
Kasatkina et al191 (which used the Coefficient of Mental Development, Gnome 
Method) a threshold was given for the overall scale out of 100 (80) but not for the 
subscales (it was the Cognitive subscale that was used for meta-analysis). Therefore 
for the subscales in Kasatkina et al191, we used 16 as a threshold, as the subscales 
were out of 20, and 16 multiplied by five is 80 (much as 20 multiplied by five is 100), 
thus 16 gave a good approximation of the total value. 
 The Language Development Survey  (used by Henrichs et al192) had a threshold 
substantially lower than the other studies, since the threshold is not the individual 
score on the test, but the percentile score of the individual (in this case the 15th 
percentile of the population).  Most of the other studies had fairly consistent cut-off 
points (only three are outside of the 80 to 90 radius).  As most of the studies used a 
threshold of 1 standard deviation below the population mean, whilst official diagnosis 
of Intellectual Disability requires an IQ lower than 2 standard deviations, it was 
decided the meta-analysis should be named “indicators of intellectual disability” 
rather than intellectual disability itself.  
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Figure 7: Intellectual disability thresholds 
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Figure 8 shows the chosen outcome measures for ADHD. Andersen et al151 based 
their study on hospital diagnosis of ADHD (and prescription of ADHD medication) 
therefore did not have a threshold and was not included in Figure 8. The Child 
Behaviour Checklist (externalising) has a much higher threshold than the other 
outcome scales as it measured against a population percentile rather than a cut-off 
in the outcome measure, hence is probably not an outlier.   
Figure 9 shows the chosen outcome measures for autism. Unlike Munoz et al193 
(which used a DSM-IV diagnosis and gave a threshold), Yau et al194 used DSM-IV to 
diagnose autism yet did not give a threshold value; hence it was not included in 
Figure 9 (same with Andersen et al151 which used hospital diagnosis). The Childhood 
Autism Rating Scale (used by George et al195) seems to use a seemingly lower 
threshold than the Clinical Pervasive Developmental Problems, though it is the only 
study to use an absolute cut-off on a given scale, Clinical Pervasive Development 
Problems being a population percentile measure and the other two (not in Figure 9) 
being absolute values; hence it was probably not as much of an outlier as it 
appeared.   
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Figure 8: ADHD thresholds 
 
 
A case was unhealthy if they scored higher than the threshold.  
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Figure 9: Autism thresholds 
 
A case was unhealthy if they scored higher than the threshold 
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Risk of Bias for Observational Studies 
A summary of the risk of bias for the observational studies is shown in Table 3. 
Questions 23 and 24 (which were about the randomization process, see Appendix 8) 
were irrelevant to this study, and questions 14 (about blinding the subjects to the 
intervention) and 19 (about compliance with the intervention) were also largely 
irrelevant. The lowest scoring question in this study was question 8, about whether 
adverse effects of the intervention were recorded, though this was also largely 
irrelevant. 
The lowest scoring relevant question was 27, since very few studies reported on the 
statistical power of the studies. Also low scoring was question 26, as many studies 
did not take into account the attrition to their population samples, and question 15, as 
many studies did not explicitly blind subjects as to whether they were in the 
hypothyroidism group or the control group.  
The two studies with the highest risk of bias were Liu et al169 and Kasatkina et al191, 
mostly because those studies gave inadequate information as to where their study 
subjects came from. The study with the lowest risk of bias was Su et al196, which 
answered positively on all relevant Downs and Black questions (except question 27). 
In total, the overall risk of bias is acceptably low as the majority of relevant criteria for 
the majority of studies have been met.       
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Table 3: Risk of Bias results.  
The rows are questions on the Downs and Black Checklist, the Columns are the studies. Green signifies reduced risk of bias, red 
increased risk of bias, orange intermediate risk and yellow uncertain or irrelevant risk. 
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Meta-Analysis for Observational Studies 
Studies Excluded from Meta-Analysis 
7 studies were outright excluded for the major part of the meta-analysis. Klein et al176 
was deemed a sister paper to Haddow et al. Data was not used from Klein et al176 
because although that study produced odds-ratios, it focussed on the untreated 
mothers (Haddow et al included mixed results for treated and untreated7) and to use 
that data would require a separate set of meta-analysis that could alter the statistical 
significance of the results. Data was not used from Korevaar et al178 as no numerical 
data (other than p-values) was given, only graph data.  
Finken et al197 used the Amsterdam Neuropsychological Tasks (ANT), a series of 
computer game style tests designed to measure cognitive functions in the form of 
response speed, response speed stability, visuomotor skills, response selection, and 
response inhibition. The study presented 11 sets of outcomes for the ANT (88 sets of 
outcomes were presented in Finken et al197 in total) with none of them being given as 
the total value of the ANT. Finken et al197 is the only study in the results to use the 
ANT method, and whilst Finken et al197 cite articles associating ANT scores with 
brain damage, it is not as well validated as other neurodevelopmental measures in 
this study. It is also unclear what NDD the ANT was actually measuring (it seems to 
measure symptoms of both intellectual disability and ADHD). Due to the confusion 
surrounding this study, it was excluded from the meta-analysis. 
Pop et al 199988, Kooistra et al198 and Ganaie et al186 were excluded as they were 
measures of psycho-motor development rather than cognitive development. Pop et 
al 199988 looked at the association between maternal hypothyroxinaemia and 
Bayley’s Psychomotor Development index, Kooistra et al198 looked at maternal 
hypothyroxinaemia and the Neonatal Behavioural Assessment Scale (NBAS, which 
largely measures reflexes rather than cognitive functions) and Ganaie et al186 looked 
at overt hypothyroidism and NBAS.  
For Behrooz et al199, the IQ results from that study were used in the meta-analysis. 
Table 4 of Behrooz et al199 contained results for other psychometric tests, including 
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results for a continuous performance test. However, 3 outcomes for the continuous 
performance test were given, none of which was described as the total value. There 
were 38 outcomes displayed on table 4, equal to the 38 participants in the study, 
seriously questioning the statistical significance of any result in table 4. Hence all the 
results from Behrooz et al199 table 4 were excluded. 
Though the studies that used Beta values as results were excluded from the 
statistical analysis (including Ghassabian et al 2011119, Williams et al 2012179, Julvez 
et al200, Chevrier et al201, Oken et al182, Modesto et al202, Craig et al10 and Murphy et 
al190 (which used confidence intervals rather than standard deviations for its mean 
results, hence was treated as a beta value despite using the Mann-Whitney U test) 
these studies were included as narrative analysis for this thesis (see page 55). The 
narrative analysis appears after the summary of the meta-analysis in each section.  
Having searched the literature, the following sets of narrative and meta-analysis will 
demonstrate whether the association between a given NDD and maternal 
hypothyroidism is robust based on the evidence found, thus answering the research 
questions of this thesis.    
Nature of studies not formally analysed 
Finken et al197 showed that maternal hypothyroxinaemia in the 10th percentile 
resulted in a 41.3 (20.3 to 62.4) ms slower response speed on the Amsterdam 
Neuropsychological Tasks in the least adjusted model (down to 39.5 (17.6 to 61.4) 
ms in the most adjusted model), with decreased statistical significance at lower 
percentiles (possibly due to a smaller number of children). Furthermore, the study 
also associated on an increased risk with overt hypothyroidism, with those children 
born to mothers in both the 10th percentile fT4 and 90th percentile TSH had 71.3 (14.7 
to 127.9) ms slower response speed, the model used not shown. The study was also 
quite large with 1765 participants. However, it is not clear whether mean reaction 
time is the most important feature of the ANT, and it is certainly not the total, hence 
this result may be the result of selective reporting (most of the other results in the 
study were insignificant).    
Behrooz et al199 did find a negatively significant association between subclinical 
hypothyroidism and commission errors in the continuous performance task (p=0.04). 
However, this result was not mentioned in the text of the article, and considering the 
79 
 
large number of outcomes reported in Table 4 of Behrooz et al199 (38, equal to the 
number of participants) was likely to be a statistical false positive (a hypothesis 
further supported by the fact that the other two outcomes related to the continuous 
performance task gave insignificant associations). If this result was allowed in, the 
cases scored lower than the controls, possibly indicating a reduced risk of ADHD, 
which could have affected the results for the ADHD and subclinical hypothyroidism 
meta-analysis.  
The Noten et al175 article was unavailable for data extraction, hence was excluded 
from this study, however some information was available from a scientific poster. 
The study measured the association between maternal hypothyroxinaemia and their 
children’s school performance (similar to Päkkilä et al 2015184). The study found a 
negatively significant association between maternal hypothyroxinaemia and their 
children’s arithmetic skills, with an odds ratio of 1.86 (1.24-2.79). Our study did not 
do a meta-analysis on school performance; hence whether it could have been fitted 
into the study is questionable. Noten et al also measured Language development in 
the children (which could have been included in the indicative of intellectual disability 
meta-analysis), there the odds ratio was 1.36 (0.9-2.06), thus insignificant175.  
The Si et al181 article was available, but was written in Traditional Chinese script, and 
though a Chinese speaker was available, they had difficulty with Traditional script, 
hence to save time this article was excluded. Some information could be gained from 
the abstract, which was available in English. In this study, after the mothers had their 
thyroid hormones measured and had given birth, the mother-child pairs were 
grouped according to the child’s Denver Development Screen Test (DDST) that is 
with a delay group and a control (normal) group. The differences in maternal thyroid 
hormones between the groups were then measured. The delay group had 
significantly higher TSH levels than the control group (t=4.906, p <0.05), though 
whether this is selective reporting for the abstract is not clear. This article could have 
been fitted into the indicative of intellectual disability and subclinical hypothyroidism 
meta-analysis, and may have strengthened the association. 
We found two conference abstracts studying the link between maternal 
hypothyroidism and neurodevelopmental disorders (Alvarez et al203 and Naiki et 
al204) but were unable to find full articles linked to these studies; hence these studies 
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were excluded in the results. Alvarez et al studied the association between maternal 
thyroid levels and the children’s Bayley Scale scores. The study found an 
association between high maternal TSH and reduced Psychomotor development 
(adjusted beta value = -1.05, p = 0.038), whilst finding no association between any 
thyroid hormone and Mental development. Whilst the analysis of motor development 
was not a major part of this meta-analysis, the results could have been important for 
the indicators of intellectual disability meta-analysis, possibly weakening the 
association. However, considering that this study used regression coefficients to 
present their results, this information probably couldn’t go into the forest plot. Naiki et 
al studied the association between maternal thyroid dysfunction (and maternal 
thyroid hormone levels) and the IQ of the children (measured using the Wechsler 
Intelligence Scale for Children IV). All of the children born were within the normal 
range of IQ (82 to 127) and no linear association between the thyroid hormones and 
IQ was found (TSH p =0.08, fT4 p=0.36). If a full article was found, this study could 
have provided an extra study for the overt hypothyroidism and indicators of 
intellectual disability meta-analysis (which was lacking in studies), though the meta-
analysis would still have come out as weak.  
Overall, it seems the studies not formally included in the analysis were unlikely to 
have made that much difference to the overall results.       
ADHD and overt hypothyroidism 
Only one study dealing with overt hypothyroidism and ADHD was found, hence no 
meta-analysis could be performed. Andersen et al151 investigated the link between 
hospital diagnosed thyroid disease and ADHD, either based on hospital diagnosis or 
by prescription of ADHD medication. It estimated a hazard ratio for ADHD and 
maternal overt hypothyroidism (after adjustments) as 1.10 (0.98-1.25). 
Though Andersen et al151 was a large data-base study (857,014 singletons were 
screened) it is only one study, thus the observational association between overt 
hypothyroidism and ADHD remains unclear, though it appears there is no evidence.    
ADHD and subclinical hypothyroidism 
Figure 10 shows the two studies investigating the link between ADHD and subclinical 
hypothyroidism used in the meta-analysis (Haddow et al and Päkkilä et al 2014118). 
Two separate outcomes were given for boys and girls in Päkkilä et al 2014118; 
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however the original research team donated us an odds ratio with the genders 
merged. Figure 10 showed that the pooled odds ratio for these studies was 1.58 
(0.50-5.00), making the association between ADHD and subclinical hypothyroidism 
insignificant.  
Modesto et al202 analysed the association between maternal subclinical 
hypothyroidism (defined as normal fT4 with TSH higher than 2.5 mIU/l) and ADHD as 
measured by the Conners Parent Rating Scale-Revised at 8 years. After fully 
adjusting their model, they came to a beta value of -0.01 (-0.07 to 0.05), deeming the 
association insignificant. Chevrier et al201 analysed the association between 
continuous TSH levels in the mother and ADHD in the child. This was measured 
using both the Child Behaviour Checklist and the Kiddies Continuous Performance 
Test at 5 years, the latter outcome being used in this analysis (namely as it is a 
direct test rather than a parent reported test, thus less biased). The beta value came 
out as -0.75 (-4.61 to 3.12), deeming it insignificant. Ghassabian et al 2011119 
analysed the association between continuous TSH in the mother and externalising 
behaviour in the child, as measured by the Child Behaviour Checklist. The beta 
value came out as 0.22 (0.04 to 0.40), deeming it significant. 
Considering the result of the forest Plot (see Figure 10) it seems that there is no 
evidence for an association.  
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Figure 10: Forest plot of ADHD and subclinical hypothyroidism studies. 
 
A circle before the Study means the odds ratio was calculated by the authors of this thesis, the absence of a circle means the odds 
ratio was taken from the study. A green circle means the study shows the same significance as the authors of the study 
demonstrated, a red circle means the study shows greater significance than the authors of the study demonstrated.   
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ADHD and hypothyroxinaemia 
Figure 11 shows the two studies measuring the association between maternal 
hypothyroxinaemia and ADHD used in the meta-analysis (Munoz et al and Päkkilä et 
al 2014118). The odds ratio for Munoz et al193 was calculated using the Suissa and 
Whitehead method. For the Päkkilä et al 2014118 results, an odds ratio for both 
genders merged was given to us by the original research team. Figure 11 showed 
that the pooled odds ratio for these studies was 3.58 (0.07-172.66), making the 
association between maternal hypothyroxinaemia and ADHD insignificant.   
Modesto et al202 investigated the link between maternal hypothyroxinaemia (defined 
as fT4 below the 5th percentile and TSH between 0.1-2.5 mIU/l) and ADHD. They 
also used alternative definitions of hypothyroxinaemia, the one chosen for this 
analysis being the one where thyroid hormone samples were taken at less than 13 
weeks (as maternal thyroxine is believed to be more important in early pregnancy). 
The fully adjusted beta value came out as 0.13 (-0.01 to 0.26), deeming the 
association insignificant. Chevrier et al201 investigated the link between continuous 
fT4 and ADHD. The beta value came out as 7.52 (-4.86 to 19.91), deeming the 
association insignificant. Ghassabian et al 2011119 investigated the link between 
continuous fT4 and externalising behaviour. The beta value came out as -0.02 (-0.16 
to 0.2), deeming the association insignificant 
Considering the result of the forest plot (see Figure 11), it seems there is no 
evidence for an association.  
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Figure 11: Forest plot of ADHD and hypothyroxinaemia studies.   
 
A circle before the Study means the odds ratio was calculated by the authors of this thesis, the absence of a circle means the odds 
ratio was taken from the study. A green circle means the study shows the same significance as the authors of the study 
demonstrated, a red circle means the study shows greater significance than the authors of the study demonstrated.   
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ASD and overt hypothyroidism 
Figure 12 shows the two studies that investigated the link between autism and overt 
hypothyroidism (Andersen et al151 and George et al195). Figure 12 showed that the 
pooled odds ratio for these studies was 2.05 (0.66-6.35), deeming the association 
insignificant.  
Considering the forest Plot (see Figure 12) it seems there is no evidence for an 
association between maternal overt hypothyroidism and autism (despite both studies 
giving a positive result), however with only two studies it is still unclear (even though 
Andersen et al151 was a very large study).  
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Figure 12: Forest plot of ASD and overt hypothyroidism studies. 
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ASD and subclinical hypothyroidism 
Figure 13 shows the two studies that investigated the link between maternal 
subclinical hypothyroidism and autism (Yau et al194 and Román et al8). Both of these 
studies measured continuous TSH against those with predefined autism.  Figure 13 
showed that the pooled odds ratio of the studies was 0.62 (0.23-1.65), deeming the 
association insignificant.  
Considering the forest plot (see Figure 13), it seems that there is no evidence for an 
association between subclinical hypothyroidism and autism; however with only two 
studies the result is unclear.  
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Figure 13: Forest plot of ASD and subclinical hypothyroidism studies. 
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ASD and hypothyroxinaemia 
There was only one study investigating the link between maternal hypothyroxinaemia 
and autism, hence no meta-analysis could be performed. Román et al investigated 
the link between severe hypothyroxinaemia (defined as fT4 below the 5th percentile 
with TSH between 0.03 and 2.5 mIU/l) and autism (defined as those who scored 
within the 98th percentile of the Pervasive Developmental Problems subscale of the 
Child Behaviour Checklist). It estimated the odds ratio between maternal 
hypothyroxinaemia and autism to be 2.6 (1.3-5.18). 
As there is only one study on the link between maternal hypothyroxinaemia and 
autism, the evidence is unclear, though the one study did find a strong effect.  
Indicators of intellectual disability and overt hypothyroidism 
Figure 14 shows the two studies that investigated the link between maternal overt 
hypothyroidism and indicators of intellectual disability (Liu et al169 and Päkkilä et al 
2015184). We attempted to calculate an odds ratio for Liu et al169 directly from 
discrete data in the study. However, none of the children born to mothers with overt 
hypothyroidism had IQs below the threshold of 90; hence the odds ratio came out as 
zero. Despite attempts to rectify this, the metan function in STATA automatically 
excluded Liu et al169 (see Figure 14). 
Thus, the only available odds ratio for maternal overt hypothyroidism and indications 
of intellectual disability was Päkkilä et al 2015184. Päkkilä et al 2015184 measured the 
association between hypothyroidism (overt and subclinical hypothyroidism were 
mixed in the study, overt hypothyroidism defined as fT4 lower than 11.09 pmol/l and 
TSH greater than 3.5 mIU/l) and IQ (as measured using the Wechsler Intelligence 
Scale for Children-Revised). It came to an odd ratio of 1.05 (0.55-2.02), deeming the 
association insignificant.  
It seems that there is no evidence for an association between maternal overt 
hypothyroidism and indicators of intellectual disability, but with only two studies the 
results are unclear.  
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Figure 14: Forest plot of indicators of intellectual disability and overt hypothyroidism studies. 
 
A circle before the Study means the odds ratio was calculated by the authors of this thesis, the absence of a circle means the odds 
ratio was taken from the study. A green circle means the study shows the same significance as the authors of the study 
demonstrated, a red circle means the study shows greater significance than the authors of the study demonstrated.   
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Indicators of intellectual disability and subclinical hypothyroidism 
Figure 15 shows the 9 studies in total used in the meta-analysis. Smit et al205, 
Behrooz et al199 and Williams et al 2013177 all had their odds ratios calculated using 
the Suissa and Whitehead methods, whilst for Chen et al187 we calculated the odds 
ratios directly from the data. Behrooz et al199 presented the results given as 
insignificant (no child came out with an IQ <85), however after conversion, the odds 
ratios came out showing positive associations.  The pooled odds ratio of the studies 
came out as 2.01 (0.80-5.08), deeming the association insignificant (see Figure 15). 
Figure 16 suggested that there may be a strong publication bias in favour of the 
association.   
Julvez et al200 investigated the link between maternal subclinical hypothyroidism 
(measured as TSH at the 90th, 95th and 97.5th percentiles, with an ordinal value 
showing the trend) and infant cognitive development (as measured using the Bayley 
Scales Mental Development Index at 14 months). For TSH in the 97.5th percentile, 
the beta value came out as 2.29 (-2.78 to 7.36), deeming the association 
insignificant. Oken et al182 investigated the link between maternal subclinical 
hypothyroidism (measured as TSH higher than 2.5 mU/l) and intellectual 
development (as measured using the Peabody Picture Vocabulary Test at 3 years). 
The beta value came out as 2.5 (-0.8 to 5.7), deeming the association insignificant. 
Murphy et al188 investigated the link between maternal subclinical hypothyroidism 
(defined as either TSH higher than 4 mIU/l or fT4 levels in the 2nd percentile, having 
both these traits constituted overt hypothyroidism and were excluded, thus half of the 
case sample technically had hypothyroxinaemia) and IQ (measured using the 
Wechsler Intelligence Scale for Children-IV).   The mean difference between the 
controls and cases IQs was 5.24 (Mann-Whitney confidence intervals= 0.144 to 
10.330), deeming the association positively significant. Chevrier et al201 investigated 
the link between continuous maternal TSH and numerous measures of cognitive 
development at 5 years, the chosen one for this thesis being the Wechsler Preschool 
and Primary Scale of Intelligence 3rd edition, Performance IQ subscale. The beta 
value was estimated to be -2.26 (-5.57 to 0.74), deeming the association 
insignificant.   
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Williams et al 2012179 deals with preterm births (with thyroid hormones measured at 
birth) whilst Williams et al 2013177 deals with full term births (with thyroid hormones 
measured at 10 weeks, 34 weeks and at birth). Williams et al 2012179 measured the 
association between maternal subclinical hypothyroidism (defined as TSH greater 
than 3 mIU/l) against intellectual development (as measured by the McCarthy 
Scales). The beta value came out as -13.541 (-23.931 to -3.151), deeming the 
association negatively significant (subclinical hypothyroidism associated with 
decreased McCarthy score). 
Considering the results of the forest plot (see Figure 15), it seems there is no 
evidence for an association between maternal subclinical hypothyroidism and 
indicators of intellectual disability.   
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Figure 15: Forest plot of indicators of intellectual disability and subclinical hypothyroidism studies. 
 
A circle before the Study means the odds ratio was calculated by the authors of this thesis, the absence of a circle means the odds 
ratio was taken from the study. A green circle means the study shows the same significance as the authors of the study 
demonstrated, a red circle means the study shows greater significance than the authors of the study demonstrated.   
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Figure 16: Funnel plot of indicators of intellectual disability and subclinical 
hypothyroidism studies. 
 
 
 
 
 
 
 
95 
 
Intellectual disability and hypothyroxinaemia 
Figure 17 shows the 8 studies used for the meta-analysis. Pop et al 2003206, 
Kasatkina et al191, Suarez-Rodriguez et al207, Grau et al208 and Ghassabian et al 
2014180 had their odds ratios calculated using the Suissa and Whitehead method. 
The pooled odds ratio of the studies came out as 2.69 (1.47-4.95), deeming the 
association positively significant (see Figure 17). Figure 18 showed some evidence 
of publication bias in favour of an association, most likely driven by one study with 
both a high odds ratio and high standard error, namely Suarez-Rodriguez et al207.  
Craig et al investigated the link between maternal hypothyroxinaemia (defined as fT4 
lower than the 3rd percentile with TSH between 0.1-3.5 mIU/l) and infant cognitive 
development (measured using Bayley Scale 3, Cognitive subscale). The beta value 
came out after adjustments as -1.4 (-4.9 to 2.0), deeming the association 
insignificant. Julvez et al200 investigated the link between maternal 
hypothyroxinaemia (defined as fT4 in the 10th, 5th and 2.5th percentiles, with an 
ordinal value showing the trend) and infant cognitive development. For fT4 in the 2.5th 
percentile, the beta value came out as -4.20 (-8.62 to 0.22), deeming the association 
insignificant. Williams et al 2012179 investigated the link between maternal 
hypothyroxinaemia (defined as fT4 lower than 11.7 pmol/l) and intellectual 
development. The beta value came out as 14.466 (0.453 to 28.479), meaning there 
was a significant positive association between maternal hypothyroxinaemia and IQ 
(decreased fT4 led to a decreased risk of intellectual disability). Chevrier et al201 
investigated the link between continuous fT4 and IQ at 5 years. The beta value came 
out as -4.12 (-13.73 to 5.49), deeming the association insignificant. Oken et al182 
investigated the link between continuous tT4 and intellectual development. The beta 
value came out as -0.1 (-0.7 to 0.5), deeming the association insignificant. 
Considering the forest plot (see Figure 17), it seems there is some evidence for an 
association between maternal hypothyroxinaemia and indicators intellectual 
disability. 
Note that many differing thresholds were used to define hypothyroxinaemia (see 
Figure 6). In Figure 19 the meta-analysis was limited to hypothyroxinaemia as 
defined as fT4 below the 5th percentile, here the pooled odds ratio came to 2.83 
(1.41-5.68), also deeming the association positively significant. Figure 20 showed 
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evidence of publication bias in favour of an association, driven by one study with 
both a high odds ratio and high standard error, namely Li et al183. Julvez et al200 and 
Craig et al10 both used fT4 thresholds below the 5th percentile and both showed 
insignificant results. Despite this, it does seem that there is some evidence for an 
association between 5th percentile fT4 in pregnancy and indicators of intellectual 
disability.  
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Figure 17: Forest plot of indicators of intellectual disability and hypothyroxinaemia studies. 
 
A circle before the Study means the odds ratio was calculated by the authors of this thesis, the absence of a circle means the odds 
ratio was taken from the study. A green circle means the study shows the same significance as the authors of the study 
demonstrated, a red circle means the study shows greater significance than the authors of the study demonstrated.   
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Figure 18: Funnel plot of indicators of intellectual disability and 
hypothyroxinaemia studies. 
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Figure 19: Forest plot of indicators of intellectual disability and hypothyroxinaemia (5th percentile fT4 levels) studies. 
 
A circle before the Study means the odds ratio was calculated by the authors of this thesis, the absence of a circle means the odds 
ratio was taken from the study. A green circle means the study shows the same significance as the authors of the study 
demonstrated, a red circle means the study shows greater significance than the authors of the study demonstrated.   
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Figure 20: Funnel plot of indicators of intellectual disability and 
hypothyroxinaemia (5th percentile fT4 levels) studies. 
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Results for Randomized Controlled Trials 
In total, only one Randomized Control Trial was found for question 2, that being 
Lazarus et al11. This was not enough to perform a meta-analysis, though this 
study was analysed. 
Exposure Characteristics for Randomized Controlled Trials 
In Lazarus et al, the threshold values used were fT4 lower than the 2.5th 
percentile and/or TSH higher than the 97.5th percentile. The absolute values for 
these thresholds is not given, however the 95% confidence ranges are given, 
and the lower value for fT4 is 8.4 pmol/l, and the higher value for TSH is 3.65 
mIU/l. This range of values meant that overt hypothyroidism, subclinical 
hypothyroidism and hypothyroxinaemia were all included at once. Those people 
assigned to the screening group were immediately tested for hypothyroidism, 
and those with thyroid hormones beyond the thresholds were put on a course of 
levothyroxine treatment. Those people assigned to the control group had their 
serum samples taken, yet their thyroid hormones were only measured after 
delivery of the child.    
 
 
Outcome Characteristics for Randomized Controlled Trials 
Three outcome measures were used in this study: the Wechsler Preschool and 
Primary Intelligence Scale-3rd edition, the Child Behaviour Checklist (CBCL) 
and the Behaviour Rating Inventory of Executive Function-preschool version 
(Brief-P). The CBCL and Brief-P were measured in case those aspects of the 
child’s behaviour affected their IQ score. A threshold value was given for the 
Wechsler scale of an IQ less than 85, for the CBCL the significance threshold 
was above the 98th percentile (though mean values are what were presented) 
and for Brief-P the threshold was greater than 65. These characteristic were 
measured once the child was 3 years old.    
Risk of Bias for Randomized Controlled Trials 
With Lazarus et al, the main concern is that no placebo was put in place for the 
control group, they were simply untreated (as opposed to say, making them go 
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through a dummy procedure followed by giving them a placebo). However, 
given the nature of the study, where the psychological assessments were 
performed by psychologists on young children (rather than testing the effects of 
a drug on adults) this aspect may be less relevant. With an attrition rate higher 
than 20%, there is a strong possibility that there was attrition bias going on in 
this study, and no attrition analysis was provided in the article. Despite these 
things, the overall risk of bias in Lazarus et al seemed low (see Table 4).  
 
 
Table 4: Cochrane Checklist for Lazarus et al 
Entry Judgement Support for judgement 
Random sequence 
generation (selection 
bias) 
Low risk “On receipt of samples, 
women were randomly 
assigned with the 
use of a computer-
generated block design to 
the screening or control 
group” 
Allocation concealment 
(selection bias) 
Low Risk Whole process done 
using a computer 
Blinding of participants 
and personnel 
(performance bias) 
High Risk No placebo was given to 
the control group 
Blinding of outcome 
assessment (detection 
bias) (patient-reported 
outcomes) 
Low Risk No patient reported 
outcomes are described 
Blinding of outcome 
assessment (detection 
bias) (Mortality) 
Low Risk “….psychologists who 
visited the children’s 
home and who 
were unaware of the 
group assignments” 
Incomplete outcome data 
addressed (attrition bias) 
(Short-term outcomes  (2-
6 weeks)) 
High Risk 22% of screening group 
and 27% of the control 
group were unavailable 
for psychological 
assessment 
Incomplete outcome data 
addressed (attrition bias) 
(Longer-term outcomes  
(>6 weeks)) 
Unclear Risk Little follow up after first 
psychological 
asessement.  
Selective reporting 
(reporting bias) 
Low risk All things mentioned in 
the methods appear in the 
results, plus there is 
Supplementary data.  
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Data Analysis for Randomized Controlled Trials 
In total, none of the outcomes measured were deemed significant by the 
authors of Lazarus et al (see Table 5). When we converted the scores for IQ 
less than 85 into odds ratios, we came to an odds ratio of 0.834 (0.551-1.262), 
confirming that the association was insignificant. How the confidence intervals 
for the difference values were calculated is not clear, though it was probably the 
standard method209.  Most of the p-values were calculated using a t-test, though 
the IQ less than 85 was tested using a χ-squared test. 
Lazarus et al also used Risk ratios showing the different relative risks of low IQ 
between the screening and control groups depending on differing IQ thresholds, 
and based on whether the screening group had actually complied with the 
intervention or not. None of these results were significant. 
In conclusion, the one RCT on whether levothyroxine treatment during 
pregnancy reduces the incidence and/or symptoms of a neurodevelopmental 
disorder has come out with a negative result.   
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Table 5: Results from Lazarus et al 
Test Screening 
Group 
(N = 390) 
Control Group 
(N = 404) 
Difference 
(95% CI) 
(Control 
Group − 
Screening 
Group) 
p-value 
IQ     
Mean 99.2±13.3 100.0±13.3 0.8 (−1.1 to 
2.6) 
0.40 
<85 (% of 
children) 
12.1 14.1 2.1 (−2.6 to 
6.7) 
0.39 
CBCL T 
score‡ 
    
Mean 44.4±12.4 45.1±13.6 0.7 (−1.2 to 
2.5) 
0.49 
Brief-P T 
score§ 
    
Median 40 40 0 0.59 
Interquartile 
range 
47–55 47–55   
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Chapter 4: Discussion 
The first research question of this thesis was “Is there an association between 
hypothyroidism in mothers and neurodevelopmental disorders in their children?” 
Our evidence shows that there is some evidence for an association between 
maternal hypothyroxinaemia and indicators of intellectual disability. Our meta-
analysis shows that there is no evidence for an association between all types of 
maternal hypothyroidism and ADHD. The association between autism and overt 
hypothyroidism is insignificant owing to large confidence intervals (despite both 
studies (Andersen et al151 and George et al196) showing a positive result). The 
association between subclinical hypothyroidism and autism shows an 
insignificant reverse association, and only one study has investigated the link 
between autism and hypothyroxinaemia (Román et al8), which showed a 
positive result.  There is no evidence for an association between subclinical 
hypothyroidism with indicators of intellectual disability, and not enough studies 
have been done on the link between overt hypothyroidism and indicators of 
intellectual disability for a clear outcome to be determined. 
The fact that there was only a significant association between intellectual 
disability and hypothyroxinaemia is evidence against the claim that autism, 
ADHD and intellectual disability share a common aetiology, weakening the 
claims made by Owen45. Whilst these findings do support the mechanisms 
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proposed for the aetiology of intellectual disability and psychomotor impairment 
(see pages 28-29) and marginally support the proposed mechanism for autism 
(mostly due to Román et al8), they do not support the proposed mechanism for 
ADHD.  
The second research question of this thesis was “Does levothyroxine treatment 
of pregnant mothers lead to a significant drop in diagnosis and/or reduction in 
the severity of symptoms of neurodevelopmental disorders in children?” Only 
one randomized controlled trial was found on the topic, Lazarus et al11, which 
gave a negative outcome. Therefore from the current evidence it seems the 
levothyroxine treatment of hypothyroid mothers does not reduce the severity of 
NDD, though with only one RCT the evidence is not clear. These findings do not 
support the case for universal screening of pregnant mothers for 
hypothyroidism.   
Strengths and Limitations compared to other Meta-Analysis’ 
In 2015, Wang et al148 carried out a systematic review entitled “Maternal 
Thyroxine Levels During Pregnancy and Outcomes of Cognitive Development in 
Children”145. Whilst no explicit question was given for the review, the review 
aimed to answer the question of whether low maternal thyroxine was associated 
with delayed cognitive skills in the children, for which they searched EMBASE 
and Medline. They found that using a random effects analysis (much like we 
did) that there was a combined Risk Ratio of the studies they used of 3.08 
(1.83-5.18), deeming the evidence for the association strong. All the studies 
found in Wang et al148 appear in our study, including Haddow et al7 (which is 
interesting considering it was mostly based around TSH levels rather than 
thyroxine levels). 
Compared to Wang et al148, this systematic review looked at more databases, 
performed grey literature searches and forward and backward citation chasing, 
allowing a truly comprehensive look at what studies on the link between 
maternal hypothyroidism and neurodevelopmental disorders exist. Unlike Wang 
et al148, which based their statistical analysis on risk ratios, we based ours on 
odds ratios. Odds ratios have an advantage over risk ratios when dealing with 
rare diseases210 (overt hypothyroidism and diagnosed neurodevelopmental 
disorders being fairly rare). However, conventionally odds ratios are used for 
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case-control studies, whilst risk ratios are used for cohort studies210. The 
majority of studies found were cohort studies; hence the use of odds ratios 
could affect the validity of the results. 
Wang et al148 based their searches on a very specific question, namely is there 
an association between maternal thyroxine levels and child cognitive 
development. Our study by contrast looked into TSH as well as T4, differing 
types of hypothyroidism (overt, subclinical and hypothyroxinaemia) and into 
many different neurodevelopmental disorders, including indicators of intellectual 
disability (the closest to what Wang et al148 did). However, despite searching for 
many types of neurodevelopmental disorders, due to reasons of statistical 
significance (and pragmatic reasons) we only did meta-analysis for ADHD, 
autism and (indicators of) intellectual disability (due to the co-morbidity of these 
NDD). We did not do a meta-analysis on neurodevelopmental traits like reading 
and mathematics (i.e. dyslexia and dyscalculia) though we did examine 
psychomotor development in the appendix section (see Results, pages 80-81). 
Much of the data extracted from the studies (such as whether the study took 
place in a hospital or not) was not used in the final analysis. Much of the data 
that was used in this thesis is displayed in the summary table (see Table 2). 
Performing a systematic review is a learning curve; hence with the knowledge 
gained from this review, a more streamlined, relevant data extraction process 
can be developed for later systematic reviews.     
For this thesis we used the Downs and Black Checklist to measure the quality 
of the studies. Some of the questions on Downs and Black (such as the one 
about “data dredging”) were difficult to interpret, which may have affected the 
results. Furthermore, there was uncertainty on which Downs and Black 
questions were relevant and which were not, further questioning the validity of 
the quality assessment. However, many of these issues were reduced by the 
fact that two people examined the data and performed quality assessment; 
hence this risk to validity may be irrelevant. Wang et al148 used the Newcastle-
Ottawa scale to assess quality, a scale that has been criticized for having low 
inter-rater reliability211.  
Whilst the Suissa and Whitehead method has been an effective way of 
converting continuous data into odds ratios, it has not been 100% accurate, as 
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shown by the false positive result for Behrooz et al199. However, some statistical 
outliers are expected when dealing with a fairly large number of studies.  
The biggest issue in the meta-analysis is probably the inability to find an agreed 
upon method to convert the regression coefficients into odds ratios, meaning 
that eight studies could not be included in the meta-analysis. A possible method 
was found, but that required the standard error of the regression coefficients to 
be presented, and only one study (Williams et al 2012179) provided the standard 
error, hence this method was abandoned. This issue was partly overcome by 
the use of narrative analysis of the regression coefficient results, and from the 
results, it seems unlikely that they would have affected the meta-analysis 
substantially.     
When choosing whether to classify a study by which type of hypothyroidism 
(overt, subclinical or hypothyroxinaemia) there were some issues. For example, 
in many of the studies, T4 and TSH levels were measured, but were measured 
and displayed separately rather than in conjunction. Hence rather than view 
these studies as overt hypothyroidism studies, we treated them as joint 
subclinical hypothyroidism and hypothyroxinaemia studies, with the outcomes 
for both used in separate meta-analysis. However, if the results of this thesis go 
to publication, we may choose to contact the authors of these studies to discuss 
the classification issue in more depth.    
Both the issues of the regression coefficients and classifying hypothyroidism 
both stem with heterogeneity and lack of clarity in how the studies reported their 
results. This heterogeneity in reporting outcomes is something that is difficult for 
a review team to overcome, though hopefully it may advise future studies to be 
clearer and more homogenous in their reporting.   
 
Risk of Publication Bias 
As part of our systematic search, we performed grey literature searches, during 
which no new articles were found. This suggests that unpublished articles are 
not a major risk in the associations, however there is still a risk of unpublished 
results within published studies (possibly a decision by researchers to make 
their articles easier to publish). 
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The association with the highest risk of publication bias (in the results section) 
seems to be the association between subclinical hypothyroidism and indicators 
of intellectual disability (see Figure 20). This is probably due to a large number 
of low weight (small population sample and/or high levels of variance) studies in 
this association, the heaviest included study being Henrichs et al192 that 
included 3659 mother-child pairs. Larger scale studies into subclinical 
hypothyroidism and intellectual disability could correct this bias.  
The publication bias risk for hypothyroxinaemia and indicators of intellectual 
disability is also pretty weak (see Figure 22), probably due to a much higher 
number of high weight (large population sample and/or low levels of variance) 
studies compared to the subclinical hypothyroidism meta-analysis (though it is 
still possibly biased by Suarez-Rodriguez et al207 and Li et al183). 
ADHD and hypothyroidism 
An insignificant association was observed for both subclinical hypothyroidism 
and hypothyroxinaemia (and for the one study on overt hypothyroidism, 
Andersen et al151), thus it seems that the evidence for an association between 
maternal hypothyroidism and ADHD is weak. It is possible that the association 
between maternal hypothyroidism and ADHD is confounded by the child’s IQ 
(which is associated with maternal hypothyroxinaemia), hence irrelevant for 
ADHD children with normal IQ.  
There was much discussion on how to present the results from Päkkilä et al 
2014118. In Päkkilä et al 2014118, separate outcomes were given for boys and 
girls, something no other study did. It was suggested that we calculate our own 
odds ratios from the data given, however the odds ratios in the study were 
adjusted odds ratios, and it was questionable if we could adjust them in the 
same way. Indeed, the study gave no discrete data on the number of children 
born into families with more than two children, which was one of the factors 
Päkkilä et al 2014118 adjusted for. For the subclinical hypothyroidism results, we 
experimented with merging the odds ratios using a fixed effect model, and use 
that in the meta-analysis (see Appendix 12). We tried contacting the research 
team in Finland for their own, merged gender odds ratios; and after much delay 
these results were delivered to us. Considering that these results will have been 
adjusted in the same way as the results presented in the article, these were the 
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most accurate outcomes available for the Päkkilä et al 2014118 study, hence 
these were the ones used in this thesis.  
Interestingly with Modesto et al202, whilst they found the association between 
maternal hypothyroxinaemia before 13 weeks gestation and ADHD to be 
insignificant (beta value 0.13 (-0.01 to 0.26)), they found that the overall 
association of maternal hypothyroxinaemia with ADHD was significant (beta 
value 0.07 (0.003 to 0.14)) if somewhat weaker. This suggests that 
hypothyroxinaemia later in pregnancy (rather than earlier, as previously 
assumed) has a stronger association with ADHD. Munoz et al194 never specified 
when the fT4 levels were measured, and Haddow et al7 measured thyroid 
hormones on average at 17 weeks, well into the second trimester of pregnancy. 
2 studies (Ghassabian et al 2011119 and Päkkilä et al 2014118) did find an 
association between continuous TSH levels and ADHD symptoms (for Päkkilä 
et al118 the association was only significant in girls). This raises the question of 
why would continuous TSH levels show an association but not subclinical 
hypothyroidism and hypothyroxinaemia (neither of those studies found such 
associations). ADHD has been associated in the past with thyroid hormone 
resistance, where the T4 levels are high yet the TSH levels are 
unsuppressed212. Thyroid hormone resistance is often associated with 
mutations to the β thyroid receptor, resulting in the receptor being unable to 
bind to thyroxine whilst forming an inactive complex with the DNA213. Thyroid 
hormone resistance results in elevated T4 levels, which could overstimulate the 
functional α thyroid receptors, leading to symptoms of hyperthyroidism and 
ADHD (as suggested by Andersen et al151). Thus the association between 
continuous maternal TSH and ADHD could be the result of genetic thyroid 
resistance found in both the mother and child. However, these mutations are 
believed to be rare in the population, making this hypothesis less probable, 
though a weaker polymorphism causing weaker thyroid resistance than could 
be more common, which raises possibilities of a genome wide association study 
(GWAS) into ADHD and thyroid receptors. Then again, the most recent GWAS 
into ADHD did not find any thyroid receptor genes associated with ADHD at 
population level214.   
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Andersen et al151 had the advantage of being a very big study, being the biggest 
study in terms of population sample of all the studies in the meta-analysis. 
However it also had weaknesses, namely the fact that it was based on records 
from Denmark’s public health system, yet most children diagnosed with ADHD 
and Denmark are diagnosed privately215. 
Overall, it seems that more studies need to be done to investigate the link 
between maternal hypothyroidism and ADHD. The small number of studies 
investigating the link between hypothyroidism and ADHD isn’t surprising, whilst 
Munoz et al193 measured ADHD at 2 years of age; ADHD largely becomes 
significant once the child is in school, meaning the follow-up time for a study is 
much longer than measuring infant development. ADHD is generally not 
measured at 2 years of age (most children that age are hyperactive and 
inattentive) hence it is largely diagnosed at 7 years of age.    
Autism and hypothyroidism 
Despite both studies showing a significant positive association (Andersen et 
al151 and George et al195), the overall odds ratio for maternal overt 
hypothyroidism and autism came to 2.05 (0.66-6.35), deeming the association 
insignificant.  
The reason the meta-analysis came out insignificant was probably due to the 
high level of variability in the George et al195 study. This raises the possibility 
that the link between maternal hypothyroidism and autism could be being 
confounded by some other association(s). Some of these associations have 
already been mentioned in this thesis, these include: socioeconomic status, 
parental obesity, autoimmune responses against the brain, advanced parental 
age and polycystic ovarian syndrome. This study also suggests that the link 
between maternal hypothyroidism and autism may be being confounded by the 
child’s IQ (which is associated with maternal hypothyroxinaemia), thus irrelevant 
to autistic children with normal IQ.  
Indeed, George et al195 measured the association between multiple factors with 
autism risk, the most significant factors (excluding maternal hypothyroidism) 
were: excess fetal movement (11.44 (2.85-45.98)), maternal respiratory 
infection and/or asthma (6.11 (1.56-24.02)), maternal vaginal infection (5.2 
(1.72-15.73)) and family history of neurodevelopmental disorders (2.9 (1.72-
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4.88)). The fact that maternal infections (as well as maternal hypothyroidism) 
were associated with increased autism risk strongly implicates a role of 
autoimmunity in the aetiology of autism. However, a recent systematic review 
on the association between autoimmunity and autism showed that autoimmune 
hypothyroidism had the strongest link to autism132, though whether that is due to 
the low thyroxine levels or the thyroid autoantibodies or some other 
autoimmune or genetic link (many genes implicated in autoimmunity are also 
implicated in brain development216) is not clear.  
George et al195 suggested (due to their own data and previous research) that 
the main cause of autism could be increased stress exposure to the fetus. This 
hypothesis is supported by recent research (Haas et al) which showed that 
methylation of the OXT gene (which encodes the neuropeptide Oxytocin) was 
associated with decreased general sociability217 (decreased oxytocin function 
has been associated with autism218). Haas et al suggested that the cause of this 
epigenetic modification was in part exposure to social stress. This links into 
other recent research that showed an association between maternal stress and 
autism in the child, as long as the mother had the short allele of the serotonin 
transporter promoter region (5HTTLPR)219. This link between maternal stress 
and autism could be confounding the results, especially considering research 
that showed that high TSH is associated with increased levels of cortisol220, a 
key stress hormone.  
Our results suggest that the overall odds ratio for subclinical hypothyroidism 
and autism is 0.62 (0.23-1.65), deeming the evidence for an association weak, 
with both studies showing a negative result. The sole study on autism and 
hypothyroxinaemia showed a positively significant result, with an odds ratio of 
2.6 (1.3-5.18). However, the association was only significant if the fT4 levels 
were lower than the 5th percentile, continuous fT4 and fT4 in the 10th percentile 
was not significantly associated with autism. This suggests that the fetus will 
only begin to experience problems once a critical level of fT4 is reached, 
possibly because the mother’s body will actively transport T4 to the fetus221.  
Overall, it seems that more studies need to be done on the association between 
maternal hypothyroidism and autism diagnosis before a firm conclusion can be 
reached. The small number of studies into autism and hypothyroidism isn’t 
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surprising considering that fully diagnosed autism is much rarer than below 
average IQ, meaning that finding cases can be difficult.          
Intellectual disability and hypothyroidism 
For this study, we used one standard deviation (s.d.) from the population mean 
IQ to mean intellectual disability (however, Yau et al194 used a cut-off of 70, 
which could signify two standard deviations below the mean). Usually this 
meant one standard deviation from the general population, though for 
Kasatkina191 that meant one standard deviation from the control sample. 
Historically, one standard deviation was used to diagnose intellectual disability, 
which meant that 16% of the population would be diagnosed as having 
intellectual disability whilst being fully functional and not requiring special 
care222. For this reason, the diagnosis of intellectual disability was adjusted to 
two standard deviations, which only includes 3% of the population222. However, 
IQ one s.d. below the mean is still associated with many negative outcomes , in 
one study it was found that only 10% of people with an IQ one s.d. below the 
mean had incomes higher than $34,000223 (the average income in the USA). 
There are other advantages to using one s.d. below the mean; it means you 
have a much larger sample size (allowing for greater statistical significance) and 
it allows you to investigate more subtle effects on brain development, hence we 
are justified in using IQ one s.d. below the mean as our cut-off.      
Only three studies claim to have investigated the link between overt 
hypothyroidism and intellectual disability, and one of these (Haddow et al) was 
reclassified as a subclinical hypothyroidism study (even though it probably had 
some overt hypothyroidism cases in the population sample). Considering that 
Pakkila et al 2015 used a mixture of overt and subclinical hypothyroidism in 
their definition of hypothyroidism, it is arguable that the only true study on overt 
hypothyroidism and intellectual disability was Liu et al169. Crucially, in Liu et al169 
all the participant mothers in the study were treated with levothyroxine, 
questioning whether they were fully hypothyroid during pregnancy. The lack of 
studies into overt hypothyroidism and intellectual disability isn’t surprising 
considering that overt hypothyroidism is a much rarer phenomenon than 
subclinical hypothyroidism (with 1.9% of women with overt hypothyroidism 
against 7.5% of women with elevated TSH6), meaning that finding cases is 
more difficult. Overt hypothyroidism is also more closely linked to the symptoms 
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of hypothyroidism, hence is more likely to be treated before pregnancy, 
restoring the mother to a euthyroid state when tested. 
In total, 5 studies show a positive association between hypothyroxinaemia and 
indicators of intellectual disability, compared to 8 studies that show an 
insignificant association. Despite this, the meta-analysis for the association 
showed a strong association, with an overall odds ratio of 2.69 (1.47-4.95) for 
hypothyroxinaemia.  
Kasatkina et al191 were measuring the difference in development between 
children of euthyroid mothers and hypothyroxinaemic mothers treated with 
levothyroxine, hence it could be expected for the difference to be insignificant 
(Kasatkina et al191 also found a positively significant association between 
continuous fT4 and the Coefficient of Mental Development at 12 months 
(R=0.708, p=0.014)). Though Julvez et al200 reported an insignificant 
association between Bayley Mental Development and fT4 below the 2.5th 
percentile; they found a significant association between Bayley Mental 
Development and the fT4 below the 5th percentile (beta value -3.41 (-6.67 to -
0.15)) and with the ordinal value (beta value -1.38 (-2.28 to -0.17) which 
measures the trend from the 10th to 2.5th percentiles. Considering this, it is 
arguable that 7 against 6 studies show a positive association between 
hypothyroxinaemia and indicators of intellectual disability.  
There is also the issue of cut-offs used in defining hypothyroidism. For 
hypothyroxinaemia defined as fT4 below the 5th percentile, the association with 
indicators of intellectual disability are stronger (odds ratio 2.83 (1.41-5.68)). The 
one exception to this trend seems to be Craig et al10, which defined 
hypothyroxinaemia as fT4 below the 3rd percentile, yet ultimately gave an 
insignificant association. However, the value of the 3rd percentile in Craig et al 
was 11.84 pmol/l, when the other studies gave values lower than 11 pmol/l. 
Thus it seems that fT4 levels lower than 11 pmol/l could be critical in the 
development of indicators of intellectual disability. This is arguably irrelevant, 
considering that different studies use different assay techniques to measure fT4. 
Indeed, all the cohorts that had their T4 measured below the 5th percentile were 
measured using different techniques. Thus the percentile value is probably 
more important. 
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Furthermore, the cut-off value used to define subclinical hypothyroidism could 
be critical. Separate from the results, a statistical analysis on subclinical 
hypothyroidism as defined as TSH 4mIU/l or higher was done (see Appendices 
10 and 11). Of these studies, 3 studies reported a positively significant result 
against 2 that didn’t. The overall odds ratio for this association between 
indicators of intellectual disability and subclinical hypothyroidism over 4 mIU/l 
was positively significant (5.98 (1.17-30.69)). Furthermore Murphy et al188 
included a lot of hypothyroxinaemic mothers alongside the subclinical 
hypothyroid mothers, though they did not give the absolute fT4 cut-offs used and 
there were more subclinical hypothyroid mothers in the sample.  
When looking at these associations, the age of the child can be significant. For 
example, in Smit et al203, a positive association was found between maternal 
subclinical hypothyroidism and low Bayley Mental Development at 6 and 12 
months, but not at 24 months (the age we chose for the meta-analysis). This 
suggests that maternal hypothyroidism has a stronger impact on the child at 
very early stages of development (namely before school age) which then wears 
off as the child gets older. This is possibly due to the child consuming more 
iodine after birth, allowing their own thyroxine to repair the delay in brain 
development (indeed, iodine consumption in childhood is strongly associated 
with IQ224).      
The association between maternal hypothyroxinaemia and indicators of 
intellectual disability is stronger than the association with subclinical 
hypothyroidism, supporting the hypothesis that maternal thyroxine is important 
in brain development, and that maternal hypothyroxinaemia is not harmless and 
that treatment options should be considered (currently maternal 
hypothyroxinaemia treatment is not widely recommended).  
Despite these associations, the hypothesis that maternal hypothyroidism 
negatively effects brain development is called into question by the results of 
Lazarus et al11, in which screening and treating maternal hypothyroidism made 
no difference to the children’s IQ, according to their own results. Furthermore, 
there is a study in the pipeline by Casey et al (also a Randomized Control Trial) 
and early results suggest that levothyroxine treatment for maternal subclinical 
hypothyroidism and hypothyroxinaemia does not result in a decreased 
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incidence of low IQ225. This combined with the fact that the two studies on overt 
hypothyroidism and IQ gave insignificant outcomes (Liu et al169 and Päkkilä et al 
2015184), suggests either that the association between maternal hypothyroidism 
and intellectual disability is largely insignificant, or that it operates by an 
alternative mechanism.    
Recommendations for Policy, Practice and Contribution of Findings to 
Theory    
Hypothesis: Early stage hypothyroidism leads to autism, late stage iodine 
deficiency leads to ADHD/intellectual disability 
 
Our evidence suggests that hypothyroxinaemia (which may be caused by iodine 
deficiency) in the later stages of pregnancy has a bigger impact on child 
development than hypothyroidism in the early stages of pregnancy.   
The most recent systematic review found on the topic (Taylor et al226) found that 
iodine supplementation during pregnancy following mild iodine deficiency (a 
urinary iodine content of between 99 µg/l and 50 µg/l) in developed countries 
did result in improved cognitive abilities for the children226. Furthermore, an 
observational study by Moleti et al found that iodine supplementation had a 
much greater impact on child cognitive abilities than levothyroxine treatment227. 
This suggests that iodine, which allows the fetus to synthesize its own thyroxine 
once their thyroid gland is developed, is more important in intellectual 
development than maternal thyroxine. Considering that hypothyroxinaemia has 
been proposed to be caused by iodine deficiency32, it would explain why our 
findings show the association between intellectual disability and 
hypothyroxinaemia to be stronger than the association between ID and 
subclinical hypothyroidism. Vermiglio et al also demonstrated that mothers living 
in an iodine deficient area were more likely to have children with ADHD9. 
ADHD has also been linked to thyroid hormone resistance, caused by non-
responsive mutations in the thyroid β receptor212. Interestingly, Forrest et al 
demonstrated in developing chick brains that the thyroid β and α receptors had 
differing functions in the developing brain. In particular, the α receptors were 
expressed throughout brain development and were associated with neuron 
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migration, whilst the β receptors were expressed in the latter stages of brain 
development and were associated with white matter228. This is significant 
considering the association between denser cortices and increased short 
distance connections (indicative of low neuronal migration) with autism103 and of 
reduced long and short distance connections (indicative of low white matter) 
with low IQ81 and ADHD41. 
Modesto et al202 found the association between maternal hypothyroxinaemia 
before 13 weeks gestation and ADHD was insignificant after adjustments, 
however they found that maternal hypothyroxinaemia measured at any stage of 
gestation and ADHD did have a significant association (beta value 0.07 (0.003 
to 0.14)). This possibly means that ADHD had a stronger association with 
hypothyroxinaemia at later stages of gestation than it did at earlier stages of 
gestation. Furthermore, Pop et al 2003206 reported that the most significant 
association to Bayley scores was with those mothers who were 
hypothyroxinaemic consistently throughout pregnancy (hinting that the fetus can 
recover from bouts of hypothyroxinaemia). Though the overall odds ratio was 
insignificant, both studies on overt hypothyroidism and autism gave a positive 
result.  
This evidence supports the hypothesis (proposed in the introduction) that 
hypothyroidism in the early stages of pregnancy (when the fetus is dependent 
on its mothers thyroxine) results in autism and hypothyroxinaemia (linked to 
iodine deficiency) in the latter stages of pregnancy (when iodine is needed for 
the fetus’ own thyroxine) results in ADHD and intellectual disability. The 
hypothesis goes that in autism, low thyroxine levels from the mother during 
early pregnancy results in under stimulation of the neural α receptors, resulting 
in decreased neuronal migration, making the formation of long distance brain 
connections more difficult, thus stunting corpus callosum formation (resulting in 
reduced bimanual coordination resulting in most autistic symptoms). Once the 
fetus is able to synthesize its own thyroxine, if the mother is iodine sufficient, the 
β receptors will stimulate the formation of white matter connections, but only 
over short distances (this includes within the hippocampus, restoring IQ, and 
between the cortex and sub-cortex, resulting in motor stereotypies). This is 
supported by the findings of Román et al8, Andersen et al151 and George et 
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al195, but not from the meta-analysis on autism. Note that iodine deficiency has 
been associated with autism229. 
By contrast with ADHD/intellectual disability, low iodine levels mean the fetus is 
less able to synthesize its own thyroxine, meaning the β receptors remain 
unstimulated. This means the hippocampus is left undeveloped, resulting in 
reduced IQ, and the white matter connections to the frontal lobe are 
considerably less developed, resulting in ADHD symptoms. This is largely 
supported by the meta-analysis for intellectual disability and hypothyroxinaemia 
and by the results of Modesto et al202, but not by the meta-analysis for ADHD. 
Reverse Significance 
A few studies in this thesis reported a negatively significant result, in which 
measures of maternal hypothyroidism measures were associated with a 
decreased risk of neurodevelopmental disorders. Chevrier et al201 reported an 
inverse correlation between TSH and scores on the Child Behaviour Checklist 
(though this method may be subject to parental bias, hence the Kiddie’s 
Continual Performance Task was used as the main measure in the meta-
analysis), with a regression coefficient of -0.65 (-1.26 to -0.04). Chevrier et al201 
also reported a positive correlation between TSH and Mental scores on the 
Bayley Scale and Auditory comprehension on the Preschool Language Scale, 
both at 12 months of age (regression coefficients of 1.71 (0.05 to 3.37) and 2.92 
(0.59 to 5.25) respectively. Yau et al194 reported that children with autism and 
developmental delay (measured separately) were born to mothers with 
significantly lower TSH levels than the general population (adjusted odds ratios 
of 0.33 (0.12-0.91) and 0.09 (0.02-0.42) respectively). Williams et al 2012179 
reported a positive association between maternal hypothyroxinaemia and 
McCarthy score in children born prematurely, the regression coefficient being 
14.466 (0.453 to 28.479).  
The only one of these studies that could have affected the forest plots is Yau et 
al194, however it would be wise to analyse these reverse significance studies in 
depth. The results of Chevrier et al201 corroborate evidence from Andersen et 
al151, which reported a positively significant association between maternal 
hyperthyroidism and ADHD, with a reported hazard ratio of 1.18 (1.03-1.36). 
Also of significance is the age of gestation the thyroid hormones were sampled 
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at, Chevrier et al201 measured at 27 weeks, Williams et al 2012179 measured at 
34 weeks (or 1 hour after pre-term birth at 34 weeks) and Yau et al194 measured 
at 15-19 weeks. These studies were measuring thyroid hormones well into the 
second trimester of pregnancy. This supports a hypothesis (mentioned in 
Williams et al 2012179) that at later stages of pregnancy, hyperthyroidism 
becomes as bad a factor in neurodevelopment as hypothyroidism. Indeed, 
Korevaar et al178 reported a U-shaped curve for IQ <85 and maternal fT4 levels, 
highlighting the risks of maternal hyperthyroidism further (see Figure 21).   
At the later stages of pregnancy, when the fetus’ own thyroid gland is beginning 
to become active8, it is less dependent of the thyroxine of its mother; hence 
increases in thyroid hormone levels could be more damaging than decreases by 
this stage. Andersen et al151 discussed the possible mechanisms linking 
maternal hyperthyroidism to ADHD. One possible mechanism being that 
thyroxine increases the concentrations of dopamine in the developing brain230, 
with dopamine levels showing an inverse U shaped curve association with 
working memory scores231 (hence too much dopamine due to maternal 
hyperthyroidism could cause ADHD symptoms).  Hyperthyroidism has also 
been shown to be associated with increased differentiation of the neurons (as 
indicated by changes in the cytoskeletal structure232), which in turn could slow 
down the proliferation of the neurons (hyperthyroidism being linked to reduced 
neuron proliferation233), which could result in the thinner brain cortices reported 
in ADHD234. Furthermore, reduced glucose metabolism in the prefrontal cortex 
(part of the frontal lobe) has been associated with adults with a history of 
hyperactivity235; reduced glucose metabolism in the frontal lobe has also been 
associated with hyperthyroidism in adults236, suggesting that maternal 
hyperthyroidism could induce a similar hyperthyroid state in the child. These 
mechanisms could also result in the developmental delay seen in the Chevrier 
et al201, Yau et al194 and William’s et al 2012181 studies. It could also potentially 
explain why none of the meta-analysis’ for ADHD and hypothyroidism showed a 
positive result.  
Whilst our meta-analysis showed no reverse significance was seen for 
intellectual disability and ADHD, a weak reverse significance was found for the 
association between autism and subclinical hypothyroidism (0.62 (0.23-1.65), 
see Results). Though the reverse association was weak, both studies (Yau et 
120 
 
al194 and Román et al) showed some level of negative association, thus it is 
necessary to look deeper.  
The Yau et al194 study proposed a differing mechanism for their reverse 
significance result, placental abnormalities.  Trophoblast inclusions (abnormal 
folding’s of the placenta) have in one study (Walker et al) been strongly 
associated with subsequent ASD risk in the child, with 4 inclusions meaning a 
74% probability of being at risk of ASD237. Trophoblast inclusions have been 
used in the past as markers of triploid gestations and of other fetal chromosome 
abnormalities and spontaneous abortions, and seem to be caused by increased 
cell proliferation in the Cytotrophoblast 237(the placenta’s inner layer).  Walker et 
al hypothesized that the link between Trophoblast inclusions and ASD could be 
a shared overgrowth phenotype (leading to increased Cytotrophoblast growth 
and to the increased early stage brain growth reported in autism), or possibly to 
increased serotonin synthesis in the placenta affecting the brain development of 
the fetus (increased circulating serotonin has been reported in autism238). 
Furthermore, overgrowth of the trophoblast can result in increased levels of 
Human Chorionic Gonadotrophin (HcG)239, a hormone known to result in 
decreased levels of TSH16, hence the association. However, a generation R 
study found no association between HcG levels and either IQ or autism in 
relation to thyroid hormones240. Nonetheless, placental overgrowth could 
explain the weak reverse association between autism and subclinical 
hypothyroidism our evidence has shown, and it could be a confounding factor in 
the association between overt hypothyroidism and autism.  
These reverse significance results may just be random error in the overall 
picture in the link between maternal hypothyroidism and NDD’s. However, the 
mechanisms they suggest do deserve further study at a later date, possibly in 
the form of more systematic reviews.  
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Figure 21: Graph from Korevaar et al178 
 
This graph shows a U-shaped curve for IQ <85 and thyroxine levels (B and D) 
and a reverse U-shaped curve for mean IQ and thyroxine levels (A and C). With 
inclusion of overt hypothyroidism and hyperthyroidism (A and B), it seems that 
overt hyperthyroidism has a much greater negative impact on the child’s IQ than 
overt hypothyroidism.  
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Recommendations for Future Research 
Most of the studies found in this thesis have been short follow up studies, 
measuring the child’s neurodevelopment when they are still an infant, with small 
population sizes. What are needed are more long term studies, studying the 
impact of maternal hypothyroidism of the child at primary school age (5-11 
years), involving larger population cohorts. There should also be more studies 
on autism and ADHD rather than simply IQ and infant development. However 
such studies would be more expensive, though the lack of certainty surrounding 
the link between autism and maternal hypothyroidism should warrant such 
studies. It would also be worth checking if the association holds for both high IQ 
and low IQ children with autism and ADHD, in case studies are biased in favour 
of high IQ children (who may be easier to recruit into studies).      
To test the hypothesis regarding early vs late hypothyroidism, one would be 
required to measure maternal thyroid levels at least twice during pregnancy, 
once before 12 weeks (when the fetus’s own thyroid gland is inactive) and once 
after 12 weeks. This would then be followed up after 5-6 years to measure the 
diagnosis of autism, ADHD and intellectual disability and/or to measure traits 
associated with these NDD. If the hypothesis is correct, those children born to 
mothers who were overtly hypothyroid before 12 weeks would have an 
increased incidence of autism, whilst those children born to mothers with 
hypothyroxinaemia after 12 weeks would have an increased incidence of ADHD 
and low IQ. This would be a very expensive experiment due to the many 
measures, and having a long follow up period will make it difficult to keep hold 
of all the participants.   
Also, for the Lazarus study, it may be useful to follow up the children in the 
screening group to see if they have a decreased frequency of autism diagnosis 
(despite having normal IQs). 
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Recommendations for Clinical Practice     
As the association between maternal hypothyroxinaemia and indicators of 
intellectual disability is so much stronger than that with subclinical 
hypothyroidism, there should be a shift towards measuring T4 levels when 
diagnosing hypothyroidism than TSH levels. During pregnancy, diagnosis and 
treatment of hypothyroidism is recommended if TSH is above 2.5 mIU/l. This is 
according to the Endocrine Society241 and American Thyroid Association22, but 
these guidelines do not recommend treating isolated hypothyroxinaemia, 
though the European Thyroid Association does242. The reference range for fT4 
in the UK is 10-24 pmol/l 243, 10 being well under the 11 pmol/l threshold this 
meta-analysis suggested as being significant, potentially meaning that “at risk” 
mothers are being missed (though this may be irrelevant due to assay 
variability). Either way, there should be trimester specific minimum values for 
fT4, much as there already is for TSH.   
There seems to be no evidence that treatment of maternal hypothyroidism with 
levothyroxine reduces the risk of low IQ. There is however evidence of a link 
between hypothyroxinaemia and indicators of intellectual disability, and this 
opens up room for a later systematic review on the association between 
maternal iodine levels and NDD’s (currently the UK has no guidelines on iodine 
consumption during pregnancy).   
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Chapter 5: Conclusion 
It has been widely suggested that maternal hypothyroidism contributes to NDDs 
in the child, based largely on the results of the Haddow et al7 study. It is 
hypothesized that between the 8th week of pregnancy (when thyroid hormone 
receptors are first detected) and the 12th week of pregnancy (when the fetus’ 
own thyroid gland is active) that the fetus is dependent on the thyroxine of the 
mother, which is needed by the fetus to promote neuronal migration in the 
cortex and to promote the development of the cerebellum. In this thesis, the 
meta-analysis has shown no significant association between hypothyroidism 
and ADHD or autism (though this is still contentious, especially for autism and 
overt hypothyroidism). It also found no significant association between both 
overt or subclinical hypothyroidism and indicators of intellectual disability (ID), 
and the only Randomized Controlled Trial on the topic found that levothyroxine 
treatment made no difference to IQ scores. However, the meta-analysis has 
shown a positively significant association between hypothyroxinaemia and 
indicators of intellectual disability.  
The two studies on overt hypothyroidism and autism (which though insignificant 
when combined, individually were both significant) combined with the results of 
Modesto et al203 and the association between hypothyroxinaemia and ID 
suggest a possible mechanism in which early stage maternal hypothyroidism 
leads to autism (due to reduced neuronal migration due to reduced stimulation 
of the thyroid α receptor) whilst late stage maternal hypothyroxinaemia leads to 
lower IQ and ADHD symptoms (due to reduced myelination due to reduced 
stimulation of the thyroid β receptor). In the latter scenario, the 
hypothyroxinaemia is probably the result of iodine deficiency rather than 
autoimmune hypothyroidism.  
For future studies, there should be an increased follow-up period, focussing on 
children of primary school age (5-11 years) with an increased focus on more 
explicit diagnosis of NDD’s (like autism and ADHD) rather than measuring traits 
associated with intellectual disability. Whilst such an endeavour would be costly, 
the evidence of a link between overt hypothyroidism and autism is tantalising 
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enough to pursue further investigations. There should also be an increased 
emphasis on T4 measurements in general practice in addition to TSH 
measurements, as T4 (whether fT4 or tT4) seems to be more closely linked to 
neurodevelopmental outcomes than TSH.   
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Appendices 
Appendix 1: Basic Search Terms (modified depending on which data base 
used) 
(hypothyroidism OR hypothyroid OR hypothyroxinemia OR hypothyroxinaemia 
OR levothyroxine OR levothyroxin OR thyrotropin OR Liothyronine OR (thyroid  
disease) OR (thyroid  deficiency) OR (thyroid  diseases) OR thyroid OR (thyroid 
deficient) OR (thyroid dysfunction) OR (hashimoto's thyroiditis) OR (hashimotos 
thyroiditis) OR (hashimoto thyroiditis) OR (hashimotos disease) OR 
(hashimoto's disease) OR (hashimoto disease) OR thyroiditis OR (thyroid 
neoplasms)) AND (neurodevelopment OR neurodevelopmental OR 
neuropsychological OR neurocognitive OR (cognitive function) OR performance 
OR neurobehavioral OR neurobehavioural OR (nervous system development) 
OR (developmental disorders) OR Autism OR Autistic OR (brain development) 
OR (neurologic disease) OR (neurologic diseases) OR IQ OR (intelligence 
quotient) OR (learning disorders) OR (special educational needs) OR 
(intellectual disability) OR (mental retardation) OR (mentally retarded) OR 
(mental deficiency) OR (global developmental delay) OR language OR (speech 
sound disorder) OR stuttering OR (communication disorders) OR (theory of 
mind) OR cognition OR (pervasive development disorder) OR (pervasive 
developmental disorder) OR PDD OR Aspergers OR Asperger OR (social 
behaviour) OR (social behaviour) OR (childhood disintegrative disorder) OR 
(attention deficit hyperactivity disorder) OR (attention deficit disorder with 
hyperactivity) OR (attention deficit disorder) OR (hyperactivity disorder) OR 
(hyperkinetic disorder) OR hyperkinesis OR (child behaviour disorders) OR 
ADHD OR ADD OR ASD OR ASC OR AD OR dyslexia OR dyscalculia OR 
(learning difficulties) OR (reading disorder) OR (spelling disorders) OR (disorder 
of written expression) OR (specific disorder of arithmetic skill) OR (specific 
disorder of scholastic skill) OR coordination OR dyspraxia OR psychomotor OR 
motor OR (stereotypic movement disorder) OR (tic disorder) OR (Tourette 
syndrome) OR stereotypy OR (stereotyped repetitive motor movements) ) AND 
(maternal OR mother OR mothers OR pregnancy OR pregnant OR gestation 
OR gestational OR utero OR uterine OR placenta OR placental) 
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Appendix 2: Search Terms for MEDLINE Data Base Search 
Database: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and 
Ovid MEDLINE(R) <1946 to Present>, Ovid MEDLINE(R) Daily Update 
<November 18, 2015> 
Search Strategy: 
-------------------------------------------------------------------------------- 
1     hypothyroid*.ti,ab. (28893) 
2     hypothyroxin?emia.ti,ab. (456) 
3     Thyroid Disease*.ti,ab. (11143) 
4     Thyroid Hormone*.ti,ab. (30862) 
5     Triiodothyronin*.ti,ab. (15160) 
6     Thyroxin*.ti,ab. (26649) 
7     Thyroid.ti,ab. (146841) 
8     thyroid deficien*.ti,ab. (309) 
9     Thyrotropin.ti,ab. (15626) 
10     thyroid dysfunction.ti,ab. (3672) 
11     Hashimoto*.ti,ab. (5822) 
12     Thyroiditis.ti,ab. (11843) 
13     1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 (185372) 
14     Autis*.ti,ab. (29378) 
15     Language development disorder*.ti,ab. (36) 
16     Child development disorder*.ti,ab. (7) 
17     Attention Deficit Disorder with Hyperactivity.ti,ab. (233) 
18     Asperger*.ti,ab. (1826) 
19     Pervasive Development* Disorder*.ti,ab. (1843) 
20     Social responsiveness scale.ti,ab. (214) 
21     Social behavio?r.ti,ab. (7152) 
22     childhood disintegrative disorder*.ti,ab. (70) 
23     ASD.ti,ab. (11422) 
24     ASC.ti,ab. (5335) 
25     AD.ti,ab. (99735) 
26     PDD.ti,ab. (2588) 
27     ADHD.ti,ab. (16749) 
28     Attention Deficit Hyperactivity Disorder.ti,ab. (17139) 
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29     Attention Deficit Disorder.ti,ab. (1543) 
30     Hyperactivity Disorder.ti,ab. (17415) 
31     Hyperkinetic disorder.ti,ab. (193) 
32     Child Behavio?r disorder.ti,ab. (5) 
33     Child Behavio?r disorders.ti,ab. (34) 
34     Hyperkinesis.ti,ab. (678) 
35     Neurodevelopment*.ti,ab. (18701) 
36     Prenatal Exposure Delayed Effects/ or Brain/ or Nervous System/ 
(450441) 
37     prenatal exposure delayed effects.ti,ab. (2) 
38     Brain.ti,ab. (761560) 
39     Nervous System.ti,ab. (215524) 
40     neuropsychological.ti,ab. (36232) 
41     neurocognitive.ti,ab. (12078) 
42     neurobehavio?ral.ti,ab. (9323) 
43     Cognition/ (72569) 
44     cognition.ti,ab. (41565) 
45     Developmental Disabilities/ (16439) 
46     Developmental disabilities.ti,ab. (3169) 
47     IQ.ti,ab. (16510) 
48     intelligence quotient.ti,ab. (2166) 
49     Intellectual Disability/ or Intelligence/ (67891) 
50     intelligence.ti,ab. (24040) 
51     intellectual disability.ti,ab. (6741) 
52     mental* retard*.ti,ab. (30942) 
53     mental* deficien*.ti,ab. (1775) 
54     developmental disorder*.ti,ab. (6391) 
55     learning disorder*.ti,ab. (922) 
56     special education* need*.ti,ab. (235) 
57     Global developmental delay.ti,ab. (533) 
58     language disorder.ti,ab. (751) 
59     language disorders.ti,ab. (1322) 
60     Speech Sound Disorder.ti,ab. (86) 
61     Stutter*.ti,ab. (3778) 
62     Auditory Perception/ or Phonetics/ or Speech/ (52187) 
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63     Auditory Perception.ti,ab. (1173) 
64     Phonetics.ti,ab. (449) 
65     Speech.ti,ab. (60348) 
66     Fluency Disorder*.ti,ab. (66) 
67     communication disorder*.ti,ab. (1041) 
68     dyslexia.ti,ab. (4206) 
69     dyscalculia.ti,ab. (315) 
70     Mathematics/ or Cognition Disorders/ (131979) 
71     Mathematics.ti,ab. (4906) 
72     cognition disorder*.ti,ab. (158) 
73     cognition.ti,ab. (41565) 
74     Reading Disorder*.ti,ab. (383) 
75     spelling disorder*.ti,ab. (45) 
76     Writing/ or Agraphia/ or Verbal Learning/ or Pattern Recognition, Visual/ or 
Reading/ (68671) 
77     Writing.ti,ab. (19457) 
78     Agraphia.ti,ab. (663) 
79     Verbal Learning.ti,ab. (3580) 
80     Pattern Recognition.ti,ab. (11614) 
81     Reading.ti,ab. (92607) 
82     Disorder of Arithmetic Skill*.ti,ab. (5) 
83     Brain Diseases/ (50429) 
84     brain disease*.ti,ab. (4303) 
85     Disorder of scholastic skill*.ti,ab. (3) 
86     Developmental Coordination Disorder.ti,ab. (694) 
87     Motor Skills Disorders/ (2345) 
88     Motor Skills Disorder*.ti,ab. (6) 
89     Dyspraxia.ti,ab. (418) 
90     Apraxias/ (2447) 
91     Apraxia*.ti,ab. (3167) 
92     Disorder of Motor function.ti,ab. (10) 
93     Movement Disorders/ (14472) 
94     movement disorder*.ti,ab. (10556) 
95     Stereotyp* movement disorder*.ti,ab. (51) 
96     Stereotyped Behavior/ (8135) 
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97     Stereotyp* behavio?r.ti,ab. (1993) 
98     Tic disorder.ti,ab. (486) 
99     tic disorders.ti,ab. (645) 
100     Tourettes syndrome.ti,ab. (1571) 
101     Tourette syndrome.ti,ab. (2363) 
102     14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 
or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 37 or 38 or 39 or 40 or 
41 or 42 or 44 or 45 or 46 or 47 or 48 or 50 or 51 or 52 or 53 or 54 or 55 or 56 
or 57 or 58 or 59 or 60 or 61 or 63 or 64 or 65 or 66 or 67 or 68 or 69 or 71 or 
72 or 73 or 74 or 75 or 77 or 78 or 79 or 80 or 81 or 82 or 84 or 85 or 86 or 88 
or 89 or 91 or 92 or 94 or 95 or 97 or 98 or 99 or 100 or 101 (1370075) 
103     maternal.ti,ab. (190120) 
104     mother*.ti,ab. (169278) 
105     pregnan*.ti,ab. (404068) 
106     gestation*.ti,ab. (162703) 
107     uter*.ti,ab. (160526) 
108     Placent*.ti,ab. (85965) 
109     103 or 104 or 105 or 106 or 107 or 108 (807033) 
110     13 and 102 and 109 (1663) 
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Appendix 3: Search Terms for EMBASE Data Base Search 
1     hypothyroid*.ti,ab. (38340) 
2     hypothyroxin?emia.ti,ab. (566) 
3     levothyroxin*.ti,ab. (3799) 
4     thyroxin*.ti,ab. (30822) 
5     thyrotropin.ti,ab. (17306) 
6     liothyronin*.ti,ab. (258) 
7     thyroid.ti,ab. (180454) 
8     Hashimoto*.ti,ab. (7629) 
9     Thyroiditis.ti,ab. (15033) 
10     1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 (223305) 
11     Neurodevelopment*.ti,ab. (24045) 
12     Neuropsychological.ti,ab. (51588) 
13     neurocognitive.ti,ab. (17465) 
14     cognitive function.ti,ab. (30904) 
15     cognition.ti,ab. (55856) 
16     language.ti,ab. (120827) 
17     performance.ti,ab. (751432) 
18     neurobehavio?ral.ti,ab. (11776) 
19     nervous system development.ti,ab. (2783) 
20     development* disorder*.ti,ab. (8984) 
21     Autis*.ti,ab. (37855) 
22     brain development.ti,ab. (15037) 
132 
 
23     neurologic disease*.ti,ab. (5914) 
24     IQ.ti,ab. (22348) 
25     Intelligence Quotient.ti,ab. (2637) 
26     Learning disorder*.ti,ab. (1343) 
27     Special education* need*.ti,ab. (465) 
28     intellectual disability.ti,ab. (9371) 
29     mental retard*.ti,ab. (31544) 
30     mental* retard*.ti,ab. (38965) 
31     Global Developmental Delay.ti,ab. (879) 
32     mental* deficien*.ti,ab. (2128) 
33     Speech sound disorder*.ti,ab. (186) 
34     Stutter*.ti,ab. (4497) 
35     communication disorder*.ti,ab. (1403) 
36     theory of mind.ti,ab. (3415) 
37     Pervasive Development* Disorder*.ti,ab. (2488) 
38     Pervasive Child Development Disorders.ti,ab. (1) 
39     Asperger*.ti,ab. (2491) 
40     Social behavio?r.ti,ab. (8668) 
41     behavio?r disorder*.ti,ab. (5906) 
42     Attention Deficit Disorder with Hyperactivity.ti,ab. (273) 
43     Attention Deficit Hyperactivity Disorder.ti,ab. (21064) 
44     Attention Deficit Disorder*.ti,ab. (2216) 
45     Hyperactivity Disorder*.ti,ab. (21977) 
46     Hyperkinetic Disorder*.ti,ab. (538) 
47     Hyperkinesis.ti,ab. (842) 
48     ADHD.ti,ab. (23295) 
49     ASD.ti,ab. (16322) 
50     ASC.ti,ab. (7555) 
51     AD.ti,ab. (134395) 
52     PDD.ti,ab. (3887) 
53     dyslexia.ti,ab. (4985) 
54     dyscalculia.ti,ab. (428) 
55     learning difficulty.ti,ab. (226) 
56     Disorder of Scholastic Skill*.ti,ab. (7) 
57     Disorder of Arithmetic Skill*.ti,ab. (5) 
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58     Reading disorder*.ti,ab. (473) 
59     Spelling disorder*.ti,ab. (51) 
60     Coordination disorder*.ti,ab. (995) 
61     Dyspraxia.ti,ab. (659) 
62     psychomotor disorder*.ti,ab. (130) 
63     motor coordination.ti,ab. (4934) 
64     motor dysfunction.ti,ab. (3919) 
65     coordination.ti,ab. (74060) 
66     Stereotyp* movement disorder*.ti,ab. (69) 
67     Tic disorder*.ti,ab. (1325) 
68     Tourette*.ti,ab. (5379) 
69     motor stereotyp*.ti,ab. (233) 
70     stereotyp* movement*.ti,ab. (697) 
71     11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 
or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 
37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 
or 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61 or 62 or 63 or 
64 or 65 or 66 or 67 or 68 or 69 or 70 (1329872) 
72     maternal.ti,ab. (231685) 
73     mother*.ti,ab. (208091) 
74     pregnan*.ti,ab. (503979) 
75     gestation*.ti,ab. (208439) 
76     uter*.ti,ab. (196411) 
77     placent*.ti,ab. (104825) 
78     72 or 73 or 74 or 75 or 76 or 77 (980275) 
79     10 and 71 and 78 (1476) 
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Appendix 4: Search Terms for PsychInfo Data Base Search 
1     hypothyroid*.ti,ab. (1350) 
2     exp Hypothyroidism/ (616) 
3     hypothyroxin?emia.ti,ab. (35) 
4     exp Cerebral Cortex/ or exp "Migration of Nerve Cells"/ or exp 
Environmental Effects/ or exp Pregnancy/ or exp Autism/ or exp Neurotoxicity/ 
or exp Thyroid Hormones/ or exp Thyroxine/ or exp Thyroid Disorders/ or exp 
Thyrotropin/ (182139) 
5     Thyroxin*.ti,ab. (927) 
6     thyroid.ti,ab. (4102) 
7     Thyrotropin.ti,ab. (1113) 
8     Hashimoto*.ti,ab. (212) 
9     Thyroiditis.ti,ab. (159) 
10     1 or 3 or 5 or 6 or 7 or 8 or 9 (5793) 
11     Autis*.ti,ab. (35730) 
12     exp Mind/ or exp Cognitive Processes/ or exp Pervasive Developmental 
Disorders/ or exp Mother Child Relations/ or exp Learning/ or exp Attention/ or 
exp Brain/ or exp Childhood Development/ or exp Intellectual Development 
Disorder/ (830329) 
13     Mind.ti,ab. (59009) 
14     cognitive processes.ti,ab. (15194) 
15     pervasive development* disorder*.ti,ab. (2584) 
16     Child Relation*.ti,ab. (8287) 
17     Learning.ti,ab. (286133) 
18     Attention.ti,ab. (197221) 
19     Brain.ti,ab. (219749) 
20     Childhood Development.ti,ab. (926) 
21     intellectual development disorder*.ti,ab. (1) 
22     Asperger*.ti,ab. (3175) 
23     exp Interpersonal Relationships/ or exp Attention Deficit Disorder with 
Hyperactivity/ or exp Social Skills/ or exp Learning Disabilities/ (185528) 
24     interpersonal relation*.ti,ab. (12474) 
25     Attention Deficit Disorder with Hyperactivity.ti,ab. (371) 
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26     Social Skill*.ti,ab. (11714) 
27     social responsiveness scale.ti,ab. (205) 
28     exp Social Behavior/ (575826) 
29     social behavio?r.ti,ab. (13371) 
30     childhood disintegrative disorder.ti,ab. (107) 
31     exp Developmental Disabilities/ or exp Childhood Psychosis/ (14042) 
32     developmental disabilities.ti,ab. (6413) 
33     childhood psychosis.ti,ab. (205) 
34     Attention Deficit Hyperactivity Disorder.ti,ab. (18748) 
35     exp Hyperkinesis/ or exp Cognitive Ability/ or exp Executive Function/ or 
exp Attention Deficit Disorder/ (102865) 
36     hyperkinesis.ti,ab. (416) 
37     cognitive ability.ti,ab. (6118) 
38     executive function.ti,ab. (8071) 
39     Attention Deficit Disorder.ti,ab. (2072) 
40     Hyperactivity Disorder.ti,ab. (19002) 
41     Hyperkinetic disorder.ti,ab. (170) 
42     exp Behavior Disorders/ (142400) 
43     Behavio?r disorder*.ti,ab. (5601) 
44     ADHD.ti,ab. (20137) 
45     ASD.ti,ab. (9156) 
46     ASC.ti,ab. (568) 
47     AD.ti,ab. (37093) 
48     PDD.ti,ab. (1567) 
49     Neurodevelopment*.ti,ab. (8627) 
50     exp Brain Development/ or exp Cognitive Development/ or exp Neural 
Development/ or exp Infant Development/ or exp Motor Processes/ (173981) 
51     Cognitive development.ti,ab. (9707) 
52     neural development.ti,ab. (941) 
53     infant development.ti,ab. (2378) 
54     motor processes.ti,ab. (748) 
55     cerebral cortex.ti,ab. (8293) 
56     migration of nerve cells.ti,ab. (3) 
57     Neurotoxicity.ti,ab. (3414) 
58     neuropsychological.ti,ab. (37403) 
136 
 
59     neurocognitive.ti,ab. (8910) 
60     exp Cognitive Impairment/ or exp Neuropsychology/ or exp 
Neurocognition/ (45766) 
61     Cognitive Impairment*.ti,ab. (24706) 
62     Neuropsychology.ti,ab. (7317) 
63     Neurocognition.ti,ab. (964) 
64     neurobehavio?ral.ti,ab. (5224) 
65     exp Behavioral Neuroscience/ or exp Neurology/ (17177) 
66     Behavio?ral neuroscience.ti,ab. (600) 
67     neurology.ti,ab. (9539) 
68     cognition.ti,ab. (56347) 
69     IQ.ti,ab. (24238) 
70     exp Gifted/ or exp Wechsler Intelligence Scale for Children/ or exp 
Intelligence Quotient/ or exp Intelligence/ or exp Academic Achievement/ 
(101611) 
71     Gifted.ti,ab. (9928) 
72     Intelligence.ti,ab. (62168) 
73     Academic Achievement.ti,ab. (15990) 
74     mental* retard*.ti,ab. (24541) 
75     mental* deficien*.ti,ab. (2725) 
76     intellectual disability.ti,ab. (6173) 
77     exp Behavior Problems/ (25623) 
78     behavio?r problem*.ti,ab. (12627) 
79     development* disorder*.ti,ab. (5586) 
80     special education* need*.ti,ab. (1373) 
81     Global developmental delay.ti,ab. (152) 
82     exp Delayed Development/ or exp Nervous System Disorders/ or exp 
Ataxia/ (242053) 
83     Delayed development.ti,ab. (329) 
84     nervous system disorder*.ti,ab. (362) 
85     Ataxia.ti,ab. (4569) 
86     language disorder*.ti,ab. (2823) 
87     Speech sound disorder*.ti,ab. (225) 
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88     exp Phonological Awareness/ or exp Phonology/ or exp Oral 
Communication/ or exp Speech Disorders/ or exp "Articulation (Speech)"/ or 
exp Reading/ (67364) 
89     Phonological.ti,ab. (14653) 
90     Phonology.ti,ab. (2921) 
91     oral communication.ti,ab. (513) 
92     Speech disorder*.ti,ab. (1322) 
93     Articulation.ti,ab. (7533) 
94     Stutter*.ti,ab. (5068) 
95     fluency disorder*.ti,ab. (137) 
96     exp Communication Disorders/ or exp Verbal Fluency/ or exp Language/ 
(127413) 
97     communication disorder*.ti,ab. (1435) 
98     verbal fluency.ti,ab. (3625) 
99     language.ti,ab. (150888) 
100     dyslexia.ti,ab. (5749) 
101     dyscalculia.ti,ab. (420) 
102     exp Acalculia/ (404) 
103     Acalculia.ti,ab. (167) 
104     Reading.ti,ab. (93555) 
105     spelling disorder*.ti,ab. (64) 
106     exp Orthography/ or exp Spelling/ or exp Agraphia/ (6402) 
107     spelling.ti,ab. (7874) 
108     Agraphia.ti,ab. (524) 
109     Orthography.ti,ab. (1694) 
110     Disorder of Arithmetic Skill*.ti,ab. (5) 
111     exp Mathematical Ability/ or exp Mathematics/ (23631) 
112     Mathematical Ability.ti,ab. (471) 
113     Mathematics.ti,ab. (24119) 
114     Disorder of scholastic skill*.ti,ab. (4) 
115     exp Special Needs/ (3257) 
116     Special needs.ti,ab. (5172) 
117     Developmental Coordination disorder*.ti,ab. (736) 
118     exp Dyspraxia/ (639) 
119     Dyspraxia.ti,ab. (355) 
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120     Disorder of Motor function.ti,ab. (9) 
121     exp Motor Performance/ or exp Cerebral Palsy/ (19331) 
122     performance.ti,ab. (290919) 
123     Cerebral Palsy.ti,ab. (5321) 
124     Stereotyp* movement disorder*.ti,ab. (64) 
125     exp Aggressive Behavior/ or exp Eye Movements/ or exp Tourette 
Syndrome/ or exp Social Interaction/ or exp Neuropsychiatry/ (350606) 
126     Aggressive behavio?r.ti,ab. (10725) 
127     eye movement*.ti,ab. (18030) 
128     Tourette*.ti,ab. (3350) 
129     social interaction.ti,ab. (14480) 
130     neuropsychiatry.ti,ab. (2008) 
131     Tic disorder*.ti,ab. (960) 
132     exp Obsessive Compulsive Disorder/ (11181) 
133     Obsessive Compulsive Disorder.ti,ab. (11459) 
134     11 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 24 or 25 
or 26 or 27 or 29 or 30 or 32 or 33 or 34 or 36 or 37 or 38 or 39 or 40 or 41 or 
43 or 44 or 45 or 46 or 47 or 48 or 49 or 51 or 52 or 53 or 54 or 55 or 56 or 57 
or 58 or 59 or 61 or 62 or 63 or 64 or 66 or 67 or 68 or 69 or 71 or 72 or 73 or 
74 or 75 or 76 or 78 or 79 or 80 or 81 or 83 or 84 or 85 or 86 or 87 or 89 or 90 
or 91 or 92 or 93 or 94 or 95 or 97 or 98 or 99 or 100 or 101 or 103 or 104 or 
105 or 107 or 108 or 109 or 110 or 112 or 113 or 114 or 116 or 117 or 119 or 
120 or 122 or 123 or 124 or 126 or 127 or 128 or 129 or 130 or 131 or 133 
(1347815) 
135     maternal.ti,ab. (42987) 
136     mother*.ti,ab. (101585) 
137     pregnan*.ti,ab. (35990) 
138     gestation*.ti,ab. (10051) 
139     uter*.ti,ab. (3834) 
140     exp Prenatal Exposure/ (5397) 
141     prenatal.ti,ab. (14198) 
142     placent*.ti,ab. (1114) 
143     135 or 136 or 137 or 138 or 139 or 141 or 142 (153974) 
144     10 and 134 and 143 (210) 
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Appendix 5: Map Terms for CINAHL and AMED 
1. Congenital hypothyroidism 
2. Triiodothyronine 
3. Thyrotropin 
4. Thyroiditis, autoimmune 
5. Developmental Disabilities 
6. Child Development Disorders, Pervasive 
7. Articulation Disorders, Organic 
8. Motor Skills Disorders 
9. Gait Disorders, Neurologic 
10. Deaf-Blind Disorders 
11. Disorders of Excessive Somnolence 
12. Sleep Disorders, Circadian Rhythm 
13. Social Behavior 
14. Social Readjustment Rating Scale 
15. Dystonic Disorders 
16. Feeding and Eating Disorders of Childhood 
17. Mental Disorders Diagnosed in Childhood 
18. Reactive Attachment Disorder 
19. Night Terrors 
20. Dysphonia, Muscle Tension 
21. Child Behavior Disorders 
22. Neuromuscular Facilitation 
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23. Diagnosis, Neurologic 
24. Neuropsychology 
25. Intelligence 
26. Learning Disorders 
27. Students, Disabled 
28. Organic Mental Disorders, Substance-Induced 
29. Hypersensitivity, Delayed 
30. Apraxia, Developmental 
31. Prenatal Exposure Delayed Effects 
32. Agraphia 
33. Education, Special 
34. Schools, Special 
35. Communicative Disorders 
36. Articulation Disorders, Functional 
37. Speech Disorders 
38. Apraxia of Speech (Developmental) 
39. Phonetics 
40. Fluency Disorders 
41. Voice Disorders 
42. Alternative and Augmentative Communication 
43. Apraxia 
44. Sleep-Wake Transition Disorders 
45. Movement Disorders 
46. Duane Retraction Syndrome 
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47. Stiff-Person Syndrome 
48. Prenatal Diagnosis 
49. Umbilical Cord Blood Banks 
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Appendix 6: Map Terms for BNI 
1. Social Problems 
2. Spasticity 
3. Special Needs 
4. Speech disorders 
5. Attention Deficit Disorder 
6. Hyperactivity 
7. Hypersensitivity 
8. Neurological Systems and Disorders 
9. Neuroscience nursing 
10. Neurology nursing 
11. Neuroses and Phobias 
12. Learning disabilities  
13. Mental Handicap 
14. Mentally Disordered Offenders 
15. Deafness 
16. Delirium 
17. Dependency Scales 
18. Learning Problems 
19. Language 
20. Swallowing 
21. Communication 
22. Dysphagia 
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23. Eating Disorders 
24. Disabilities 
25. Prenatal care 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 7: Map Terms for Cochrane 
1. Adrenal glands 
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2. Gonads 
3. Parathyroid glands 
4. Pineal gland 
5. Pituitary gland 
6. Pituitary-adrenal  gland 
7. Dextrothyroxine 
8. Thyrotropin 
9. Thyroxine 
10. Triiodothyronine 
11. Iodine peroxidase 
12. Glycoprotein Hormones 
13. Goiter 
14. (Euthyroid Sick Syndrome) 
15. Akinetic Mutism 
16. Child Development Disorders, Pervasive 
17. Anxiety, Separation 
18. Child Behavior Disorders 
19. Developmental Disabilities  
20. Communication disorders 
21. Learning disorders 
22. Intellectual disability 
23. Mutism 
24. Schizophrenia, Childhood 
25. Tic Disorders 
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26. Stereotypic Movement Disorder 
27. Motor Skills Disorder 
28. Attention Deficit and Disruptive Behaviour Disorders 
29. Feeding and Eating Disorders of Childhood 
30. Elimination Disorders 
31. Reactive Attachment Disorder 
32. Language Development Disorder 
33. Adjustment Disorders 
34. Affective Disorders 
35. Anxiety Disorders 
36. Articulation Disorders 
37. Attention Deficit Disorder with Hyperactivity 
38. Auditory Perception Disorders 
39. Child Reactive Disorders 
40. Cognition Disorders 
41. Consciousness Disorders 
42. Conduct Disorders 
43. Memory Disorders 
44. Attention 
45. Conversion disorder 
46. Sleep Initiation and Maintenance Disorders 
47. Dysphonia 
48. Emotional Intelligence 
49. Perceptual Disorders 
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50. Psychomotor Disorders 
51. Anhedonia 
52. Confusion  
53. Catatonia 
54. Neurologic Manifestations 
55. Apraxias 
56. Polydipsia, Psychogenic 
57. Mental Fatigue 
58. Mental Recall 
59. Mental Competency 
60.  Mental Processes 
61. Delirium, Dementia, Amnestic, Cognitive Disorders 
62. Agraphia 
63. Anomia 
64. Dyslexia 
65. Speech Disorders 
66. Child Language 
67. Disorders of Excessive Somnolence 
68. Impulse Control Disorders 
69. Aphasia 
70. Echolalia 
71. Awareness 
72. Consciousness 
73. Imagination 
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74. Intuition 
75. Comprehension 
76. Cognitive (Dissonance + Reserve) 
77. Higher Nervous Activity 
78. Learning 
79. Perception 
80. Thinking 
81. Volition 
82. Mind-Body Relations 
83. Intention 
84. Executive Function 
85. Theory of Mind 
86. Anticipation 
87. Mindfulness 
88. Spatial Navigation 
89. Psychomotor Agitation 
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Appendix 8: Maternal Hypothyroidism and Neurodevelopmental Disorders Data 
extraction form 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bibliographic Information 
 
First Author  
Title  
Year  
Citation  
 
Study 
Country:   
Setting:  
Recruitment dates:   
Study design:  
Funding source:  
Notes: 
 
 
 
 
Primary Study Aims (1=yes, 0=no) 
To find an association with neurodevelopmental 
disorders (Q1) 
 
To study the effects of maternal hypothyroidism (Q1)  
To reduce the frequency of ND diagnosis (Q2)  
To reduce the symptoms of ND (Q2)  
  
  
  
  
Other  
 
Notes:  
Primary selection criteria (1=yes, 0=no) 
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Hospital  Community-based  
Research 
Centre/University 
 Organisations/other community 
locations 
 
Outdoor Environment    
Other    
Not Described    
 
Medical doctors/medical 
assistants  
 Research team 
(unspecified) 
 
Psychologists  Other Professional  
Other allied health 
professional 
 Not described  
Non-professionals     
 
Main site of intervention (1=yes, 0=no) 
Notes:  
Intervention Delivered by…(1=yes, 0=no) 
Notes:   
Exposure/intervention measured (1=yes, 0=no, N.A.=non-applicable) 
Demographics Type of hypothyroidism measured 
Age of mother  Overt hypothyroidism  
Age of child (when assessed)  Sub-clinical hypothyroidism 1 
Selected ethnic group  Maternal hypothyroxinaemia 1 
Other  Other  
Notes :                                                                         Notes:  
 
Neurodevelopmental disorder measured Excluded groups 
Intellectual disability  Any excluded group  
Autistic Spectrum Disorder    
ADHD    
Other    
Notes:                                                                             Notes 
 
Notes: 
Comparator description (1=yes, 0=no, N.A.=non-applicable) 
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Low fT4   Cut off value  
High TSH   Cut off value  
  Hormones 
measured at 
 
Levothyroxine treatment   Dosage  
  Onset of treatment  
 
Comparator group 
described 
   
Normal fT4  Untreated 
Hypothyroidism 
 
Normal TSH  Iodine treatment  
Hyperthyroidism  Other  
 
  
Notes:  
How was TSH/fT4/thyroid outcomes measured?:   
Demographic Differences between Case and Control group 
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 Outcomes 
Primary  
 
 
Secondary 
 
 
Method of Assessment 
 
Duration of Follow Up 
 
Analysis (statistics)  
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Results 
                 
           
Number lost to follow up:  
Results of analysis for neurodevelopmental outcomes (Effect size with 95% CI, 
p-values where available) 
 
 
Criteria Description Answer 
1 Is the hypothesis/aim/objective of the 
study clearly described? Must be explicit 
 
2 Are the main outcomes to be measured 
clearly described in the Introduction or 
Methods section? If the 
main outcomes are first mentioned in the 
Results section, the question should be 
answered no. ALL primary 
outcomes should be described for YES 
 
3 Are the characteristics of the patients 
included in the study clearly described? In 
cohort studies and trials, 
inclusion and/or exclusion criteria should 
be given. In case-control studies, a case-
definition and the source 
for controls should be given. Single case 
studies must state source of patient 
 
4 Are the interventions of interest clearly 
described? Treatments and placebo 
(where relevant) that are to be 
compared should be clearly described. 
 
5 Are the distributions of principal 
confounders in each group of subjects to 
be compared clearly described? 
A list of principal confounders is provided. 
YES = age, severity 
 
Risk of Bias 
For observational studies, the Downs and Black checklist (1=yes, 0=no, 
UTD=unable to determine) 
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6 Are the main findings of the study clearly 
described? Simple outcome data 
(including denominators and 
numerators) should be reported for all 
major findings so that the reader can 
check the major analyses and 
conclusions. 
 
7 Does the study provide estimates of the 
random variability in the data for the main 
outcomes? In non 
normally distributed data the inter-quartile 
range of results should be reported. In 
normally distributed data 
the standard error, standard deviation or 
confidence intervals should be reported 
 
8 Have all important adverse events that 
may be a consequence of the intervention 
been reported? This 
should be answered yes if the study 
demonstrates that there was a 
comprehensive attempt to measure 
adverse events (COMPLICATIONS BUT 
NOT AN INCREASE IN PAIN). 
 
9 Have the characteristics of patients lost to 
follow-up been described? If not explicit = 
NO. RETROSPECTIVE – 
if not described = UTD; if not explicit re: 
numbers agreeing to participate = NO. 
Needs to be >85% 
 
10 Have actual probability values been 
reported (e.g. 0.035 rather than <0.05) for 
the main outcomes except 
where the probability value is less than 
0.001? 
 
11 Were the subjects asked to participate in 
the study representative of the entire 
population from which they 
were recruited? The study must identify 
the source population for patients and 
describe how the patients 
were selected. 
 
12 Were those subjects who were prepared 
to participate representative of the entire 
population from which 
they were recruited? The proportion of 
those asked who agreed should be stated. 
 
13 Were the staff, places, and facilities where 
the patients were treated, representative 
of the treatment the 
majority of patients receive? For the 
question to be answered yes the study 
should demonstrate that the 
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intervention was representative of that in 
use in the source population. Must state 
type of hospital and 
country for YES. 
14 Was an attempt made to blind study 
subjects to the intervention they have 
received? For studies where 
the patients would have no way of 
knowing which intervention they received, 
this should be answered yes. 
Retrospective, single group = NO; UTD 
if > 1 group and blinding not explicitly 
stated 
 
15 Was an attempt made to blind those 
measuring the main outcomes of the 
intervention? Must be explicit 
 
16 If any of the results of the study were 
based on “data dredging”, was this made 
clear? Any analyses that 
had not been planned at the outset of the 
study should be clearly indicated. 
Retrospective = NO. Prospective=Yes. 
 
17 In trials and cohort studies, do the 
analyses adjust for different lengths of 
follow-up of patients, or in casecontrol 
studies, is the time period between the 
intervention and outcome the same for 
cases and controls? 
Where follow-up was the same for all 
study patients the answer should yes. 
Studies where differences in 
follow-up are ignored should be answered 
no. Acceptable range 1 yr follow up = 1 
month each way; 2 years 
follow up = 2 months; 3 years follow up = 
3months........10years follow up = 10 
months 
 
18 Were the statistical tests used to assess 
the main outcomes appropriate? The 
statistical techniques used 
must be appropriate to the data. If no tests 
done, but would have been appropriate to 
do = NO 
 
19 Was compliance with the intervention/s 
reliable? Where there was non compliance 
with the allocated 
treatment or where there was 
contamination of one group, the question 
should be answered no. Surgical 
studies will be YES unless procedure not 
completed. 
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20 Were the main outcome measures used 
accurate (valid and reliable)? Where 
outcome measures are clearly described, 
which refer to other work or that 
demonstrates the outcome measures are 
accurate = YES. ALL 
primary outcomes valid and reliable for 
YES 
 
21 Were the patients in different intervention 
groups (trials and cohort studies) or were 
the cases and controls 
(case-control studies) recruited from the 
same population? Patients for all 
comparison groups should be 
selected from the same hospital. The 
question should be answered UTD for 
cohort and case control studies 
where there is no information concerning 
the source of patients 
 
22 Were study subjects in different 
intervention groups (trials and cohort 
studies) or were the cases and 
controls (case-control studies) recruited 
over the same time? For a study which 
does not specify the time 
period over which patients were recruited, 
the question should be answered as UTD. 
Surgical studies must 
be <10 years for YES, if >10 years then 
NO 
 
23 Were study subjects randomised to 
intervention groups? Studies which state 
that subjects were 
randomised should be answered yes 
except where method of randomisation 
would not ensure random 
allocation. 
 
24 Was the randomised intervention 
assignment concealed from both patients 
and health care staff until 
recruitment was complete and 
irrevocable? All non-randomised studies 
should be answered no. If 
assignment was concealed from patients 
but not from staff, it should be answered 
no. 
 
25 Was there adequate adjustment for 
confounding in the analyses from which 
the main findings were 
drawn? In nonrandomised studies if the 
effect of the main confounders was not 
investigated or no 
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adjustment was made in the final analyses 
the question should be answered as no. If 
no significant difference 
between groups shown then YES 
26 Were losses of patients to follow-up taken 
into account? If the numbers of patients 
lost to follow-up are not 
reported = unable to determine. 
 
27 Did the study have sufficient power to 
detect a clinically important effect where 
the probability value for a 
difference being due to chance <5% 
Sample sizes have been calculated to 
detect a difference of x% and y%. 
 
 
 
Entry Judgement Support for judgement 
Random sequence 
generation (selection 
bias) 
  
Allocation concealment 
(selection bias) 
  
Blinding of participants 
and personnel 
(performance bias) 
  
Blinding of outcome 
assessment (detection 
bias) (patient-reported 
outcomes) 
  
Blinding of outcome 
assessment (detection 
bias) (Mortality) 
  
Incomplete outcome 
data addressed (attrition 
bias) (Short-term 
outcomes  (2-6 weeks)) 
  
Incomplete outcome 
data addressed (attrition 
bias) (Longer-term 
outcomes  (>6 weeks)) 
  
Selective reporting 
(reporting bias) 
  
 
Data extracted by: 
For randomised controlled trials, the Cochrane checklist (risk of bias 
measured as low risk, high risk or unclear risk) 
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Date 
Checked by: 
Date 
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Appendix 9: Outcomes used for Meta-Analysis 
Category DSM-specifications Selection Criteria Outcome Measures 
used 
Intellectual 
Disability 
 Reduced 
conceptual skills 
(such as reading, 
writing, maths and 
language) 
 Reduced social 
skills (such as 
social judgement, 
empathy and 
communication 
skills) 
 Reduced self-
management 
(such as personal 
care, job 
responsibilities 
and money 
management)   
 Measures of 
Intelligence 
Quotient (IQ). 
 Measures of 
Infant 
Cognitive 
Development. 
 Measures of 
Language 
Development 
 Measures of 
Non-verbal IQ 
 Measures of 
general 
Development
al Delay 
 Bayley Scale 
 Bayley Scale 
3, Cognitive 
 Bayley Scale 
Mental 
Development 
 Coefficient of 
Mental 
Development
, Cognition 
(Gnome 
Method) 
 Mullen 
Scales of 
Early 
Learning   
 Vineland 
Adaptive 
Behavior 
Scales 
 Gesell 
Development 
Test, 
Language 
 Language 
Development 
Survey 
 McCarthy 
Scales of 
Children’s 
Abilities 
 Peabody 
Picture 
Vocabulary 
Test 
 Snidjers-
Oomen Niet-
Verbale 
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intelligentie 
test, revisie 
 Suzuki-Binet 
IQ 
 Wechsler 
Intelligence 
Scale for 
Children  
 Wechsler 
Intelligence 
Scale for 
Children III 
 Wechsler 
Intelligence 
Scale for 
Children IV 
 Wechsler 
Preschool 
and Primary 
Scale of 
Intelligence 
Performance 
IQ 3rd edition 
ADHD  Inattention (such 
as failure to pay 
attention to details 
and difficulty 
organising tasks 
and activities) 
 Hyperactivity and 
Impulsivity (such 
as excessive 
talking, fidgeting 
and an inability to 
remain still) 
Studies that 
recorded ADHD as 
diagnosed or used a 
validated scale were 
selected. Measures 
of externalising 
behaviour were also 
included.  
 ADHD DSM-
IV 
 Child 
Behaviour 
Checklist, 
externalising 
 Conners 
Continuous 
Performance 
Task 
 Conners 
Parent Rating 
Scale, 
Revised 
Short Form 
 Hospital 
Diagnosis  
 Kiddie 
Continuous 
Performance 
Test 
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 Rutters scale 
B2 
Autism  Communication 
Deficits (such as 
delayed language 
and responding 
inappropriately in a 
conversation) 
 Overt dependence 
on routines 
(possibly resulting 
in being highly 
sensitive to their 
environment and 
being fixated on 
inappropriate 
things) 
Studies that 
recorded Autism as 
diagnosed or used a 
validated scale were 
selected. 
 Autism DSM-
IV 
 Childhood 
Autism 
Rating Scale 
(CARS) 
 Clinical 
Pervasive 
Development 
Problems 
 Hospital 
Diagnosis 
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Appendix 10: Forest Plot for indicators of intellectual disability and subclinical hypothyroidism (greater than 4 mIU/l only) 
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Appendix 11: Funnel Plot for indicators of intellectual disability and subclinical 
hypothyroidism (greater than 4 mIU/l only) 
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Appendix 12 Forest plot to calculate merged gender subclinical hypothyroidism odds ratio for Päkkilä et al 2014118. 
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